Term,P-value,Adjusted P-value,Combined Score,Genes
Collagen-Containing Extracellular Matrix (GO:0062023),2.15E-06,1.55E-04,89.05384045,COL1A1;COL1A2;LUM;SERPINE1;BGN;COL6A3;CCN2;HMCN1;FBLN5;ASPN;THBS4
Intracellular Organelle Lumen (GO:0070013),9.66E-04,0.034784425,21.87302335,COL1A1;BCAN;COL1A2;MMP16;PSMC3;MTHFD2;LUM;ECI1;GOT2;BGN;COL6A3;DLST
Golgi Lumen (GO:0005796),0.001483293,0.035599043,57.18359474,BCAN;MMP16;LUM;BGN
Adherens Junction (GO:0005912),0.006366132,0.114590381,29.11728745,MAGI1;CDHR3;HMCN1;DLL1
Lysosomal Lumen (GO:0043202),0.008703665,0.125332777,35.77231023,BCAN;LUM;BGN
Cul3-RING Ubiquitin Ligase Complex (GO:0031463),0.012729249,0.152750987,54.73825293,KLHL13;KBTBD8
Basement Membrane (GO:0005604),0.02138599,0.189429689,36.15264774,HMCN1;THBS4
Serine Protease Inhibitor Complex (GO:0097180),0.024263309,0.189429689,190.7125852,SERPINE1
External Side Of Apical Plasma Membrane (GO:0098591),0.024263309,0.189429689,190.7125852,SLC38A1
Microvillus (GO:0005902),0.032890086,0.189429689,25.21050369,VCAM1;RAPGEF3
Mitotic Spindle (GO:0072686),0.033271431,0.189429689,15.16944275,USP44;CDC7;SGF29
Dihydrolipoyl Dehydrogenase Complex (GO:0045240),0.033804687,0.189429689,115.7918426,DLST
Filopodium (GO:0030175),0.034997742,0.189429689,23.89599468,VCAM1;RAPGEF3
Perineuronal Net (GO:0072534),0.038540687,0.189429689,95.40343353,BCAN
Platelet Alpha Granule Lumen (GO:0031093),0.041622735,0.189429689,20.52967425,SERPINE1;IGF2
Perisynaptic Extracellular Matrix (GO:0098966),0.04325371,0.189429689,80.51615206,BCAN
Vacuolar Lumen (GO:0005775),0.044726454,0.189429689,12.26149807,BCAN;LUM;BGN
CMG Complex (GO:0071162),0.047943866,0.191775463,69.22044886,MCM5
Glutamatergic Synapse (GO:0098978),0.056129294,0.200198516,15.65263476,ADGRA1;NPTXR
Podosome (GO:0002102),0.057256012,0.200198516,53.32023276,VCAM1
Cell-Cell Junction (GO:0005911),0.059479797,0.200198516,7.981720705,MAGI1;CDHR3;HMCN1;DLL1
ATAC Complex (GO:0140672),0.061878221,0.200198516,47.5478141,SGF29
Actin-Based Cell Projection (GO:0098858),0.063952304,0.200198516,13.84589008,VCAM1;RAPGEF3
Platelet Alpha Granule (GO:0031091),0.070734596,0.212203787,12.56857714,SERPINE1;IGF2
Nuclear Chromosome (GO:0000228),0.079166434,0.221936709,11.25440027,BLM;MCM5
RNA Polymerase III Complex (GO:0005666),0.080143812,0.221936709,32.33951285,POLR3K
Spindle (GO:0005819),0.084282937,0.224754498,7.432048244,USP44;CDC7;SGF29
Nucleus (GO:0005634),0.092782885,0.238584562,3.293619709,ZCCHC12;BLM;TES;SATB1;ZC4H2;CDCA7;AKR1B1;DLST;PRKX;FRAT1;DUSP10;NOCT;POLD1;HES5;HNRNPA0;RFC5;LMO3;USP44;UBE2QL1;CDC7;OLIG1;PASK;MOB3B;ZEB2;PSMC3;TAF4B;MCM5;VGLL3
Mitochondrial Matrix (GO:0005759),0.096956267,0.240719006,5.530965131,MTHFD2;ECI1;GOT2;DLST
SAGA Complex (GO:0000124),0.106884161,0.256521986,20.83030537,SGF29
Intracellular Membrane-Bounded Organelle (GO:0043231),0.118446701,0.273383142,2.831807862,ZCCHC12;BLM;TES;SATB1;ZC4H2;CDCA7;AKR1B1;DLST;PRKX;FRAT1;GLRA2;DUSP10;NOCT;POLD1;CCN2;HES5;HNRNPA0;RFC5;LMO3;USP44;UBE2QL1;CDC7;OLIG1;PASK;MOB3B;ZEB2;PSMC3;TAF4B;MCM5;CD24;VGLL3
Histone Acetyltransferase Complex (GO:0000123),0.124282117,0.273383142,16.43356791,SGF29
Catenin Complex (GO:0016342),0.128578929,0.273383142,15.56618752,CDHR3
Cell-Substrate Junction (GO:0030055),0.129097595,0.273383142,4.347027041,TES;ITGA4;ITGA11;HMCN1
Rough Endoplasmic Reticulum (GO:0005791),0.137110046,0.282054953,14.03735619,TMEM97
Aggresome (GO:0016235),0.158077872,0.308934091,11.11275137,POLD1
Supramolecular Fiber (GO:0099512),0.162210517,0.308934091,10.64368118,FBLN5
Endoplasmic Reticulum Lumen (GO:0005788),0.163048548,0.308934091,3.999260227,COL1A1;COL1A2;COL6A3
SAGA-type Complex (GO:0070461),0.170415664,0.314613534,9.794207408,SGF29
Transcription Factor TFIID Complex (GO:0005669),0.186588079,0.327170702,8.38412801,TAF4B
Cortical Actin Cytoskeleton (GO:0030864),0.194556867,0.327170702,7.794244625,RAPGEF3
Sarcoplasmic Reticulum (GO:0016529),0.198512234,0.327170702,7.523076495,THBS4
Membrane Raft (GO:0045121),0.20091281,0.327170702,3.951146526,CD24;DLL1
Secretory Granule Lumen (GO:0034774),0.20217445,0.327170702,3.159453729,PSMC3;SERPINE1;IGF2
Basolateral Plasma Membrane (GO:0016323),0.204481689,0.327170702,3.861160511,SLC38A1;SLC4A4
cullin-RING Ubiquitin Ligase Complex (GO:0031461),0.209848416,0.32845839,3.731325937,KLHL13;KBTBD8
Lysosome (GO:0005764),0.233139704,0.357150185,2.409333238,BCAN;LUM;BGN;TMEM97
Extracellular Membrane-Bounded Organelle (GO:0065010),0.244503099,0.366754649,5.14610322,COL6A3
Extracellular Vesicle (GO:1903561),0.255586542,0.375555735,4.729985272,COL6A3
Cortical Cytoskeleton (GO:0030863),0.266509021,0.383772991,4.362382466,RAPGEF3
Focal Adhesion (GO:0005925),0.294913162,0.416347994,1.959944803,TES;ITGA4;ITGA11
P-body (GO:0000932),0.335379463,0.464371564,2.72230382,PSMC3
Specific Granule Membrane (GO:0035579),0.357939108,0.486256902,2.357897086,BST1
Cytoplasmic Vesicle Lumen (GO:0060205),0.432494071,0.576658761,1.499912974,PSMC3
Ficolin-1-Rich Granule Lumen (GO:1904813),0.454490552,0.59496945,1.318072998,PSMC3
Actin Cytoskeleton (GO:0015629),0.477881716,0.607329798,0.926634668,VCAM1;RAPGEF3
Asymmetric Synapse (GO:0032279),0.480802757,0.607329798,1.130704049,ADGRA1
Neuron Projection (GO:0043005),0.516454056,0.640723821,0.728741644,GLRA2;DCX;KCNN3
Postsynaptic Density (GO:0014069),0.525037575,0.640723821,0.8746341,ADGRA1
Specific Granule (GO:0042581),0.543479888,0.652175865,0.785537801,BST1
Chromosome (GO:0005694),0.554644521,0.654662385,0.735862171,BLM
Ficolin-1-Rich Granule (GO:0101002),0.59666384,0.692899944,0.573653277,PSMC3
Lytic Vacuole (GO:0000323),0.667635585,0.756314745,0.369228738,TMEM97
Nuclear Membrane (GO:0031965),0.674175042,0.756314745,0.353871357,TMEM97
Vesicle (GO:0031982),0.68687427,0.756314745,0.325463908,COL6A3
trans-Golgi Network (GO:0005802),0.696076022,0.756314745,0.305991056,CHAC1
Intracellular Non-Membrane-Bounded Organelle (GO:0043232),0.703792888,0.756314745,0.296963312,MAGI1;BLM;ZEB2;VCAM1;DCX
Nucleolus (GO:0005730),0.733911925,0.769829312,0.243396951,MAGI1;BLM;ZEB2
Nuclear Lumen (GO:0031981),0.741124429,0.769829312,0.232863098,MAGI1;BLM;ZEB2
Secretory Granule Membrane (GO:0030667),0.748445164,0.769829312,0.210865461,BST1
Early Endosome (GO:0005769),0.781217475,0.792220538,0.163004041,VCAM1
Cytoskeleton (GO:0005856),0.949575514,0.949575514,0.017218792,DCX
3'-5' DNA Helicase Activity (GO:0043138),0.002081234,0.229782644,213.2233597,BLM;MCM5
Single-Stranded DNA Helicase Activity (GO:0017116),0.005150152,0.229782644,109.1175725,RFC5;MCM5
Notch Binding (GO:0005112),0.006114406,0.229782644,95.95691213,CHAC1;DLL1
Protein Kinase Activator Activity (GO:0030295),0.009267437,0.229782644,34.46500313,IGF2;CD24;MOB3B
3'-5' Exonuclease Activity (GO:0008408),0.018016674,0.229782644,41.54941756,NOCT;POLD1
Protease Binding (GO:0002020),0.02358238,0.229782644,19.18568924,COL1A1;COL1A2;SERPINE1
cAMP-dependent Protein Kinase Activity (GO:0004691),0.024263309,0.229782644,190.7125852,PRKX
Zinc Ion Binding (GO:0008270),0.026243085,0.229782644,11.39707218,BLM;TES;MMP16;PAPPA;CXXC4
Symporter Activity (GO:0015293),0.029045598,0.229782644,145.1819826,SLC4A4
Primary Amine Oxidase Activity (GO:0008131),0.029045598,0.229782644,145.1819826,VCAM1
Cell-Matrix Adhesion Mediator Activity (GO:0098634),0.029045598,0.229782644,145.1819826,ITGA11
"Oxidoreductase Activity, Acting On The CH-NH2 Group Of Donors, Oxygen As Acceptor (GO:0016641)",0.033804687,0.229782644,115.7918426,VCAM1
Bubble DNA Binding (GO:0000405),0.033804687,0.229782644,115.7918426,BLM
Cyclic Nucleotide-Dependent Protein Kinase Activity (GO:0004690),0.033804687,0.229782644,115.7918426,PRKX
L-glutamine Transmembrane Transporter Activity (GO:0015186),0.038540687,0.229782644,95.40343353,SLC38A1
Glycine Binding (GO:0016594),0.04325371,0.229782644,80.51615206,GLRA2
Glycine Transmembrane Transporter Activity (GO:0015187),0.04325371,0.229782644,80.51615206,SLC38A1
Amino Acid:Monoatomic Cation Symporter Activity (GO:0005416),0.04325371,0.229782644,80.51615206,SLC38A1
Phosphate Ion Binding (GO:0042301),0.04325371,0.229782644,80.51615206,MTHFD2
MAP Kinase Tyrosine Phosphatase Activity (GO:0033550),0.04325371,0.229782644,80.51615206,DUSP10
MAP Kinase Tyrosine/Serine/Threonine Phosphatase Activity (GO:0017017),0.04325371,0.229782644,80.51615206,DUSP10
Protein Tyrosine/Threonine Phosphatase Activity (GO:0008330),0.04325371,0.229782644,80.51615206,DUSP10
Tat Protein Binding (GO:0030957),0.04325371,0.229782644,80.51615206,DLL1
Eukaryotic Initiation Factor 4E Binding (GO:0008190),0.04325371,0.229782644,80.51615206,EIF4EBP1
alditol:NADP+ 1-Oxidoreductase Activity (GO:0004032),0.047943866,0.229782644,69.22044886,AKR1B1
Platelet-Derived Growth Factor Binding (GO:0048407),0.047943866,0.229782644,69.22044886,COL1A2
Organic Acid:Sodium Symporter Activity (GO:0005343),0.052611263,0.229782644,60.39016494,SLC38A1
3'-5'-DNA Exonuclease Activity (GO:0008296),0.052611263,0.229782644,60.39016494,POLD1
Calcium-Activated Potassium Channel Activity (GO:0015269),0.052611263,0.229782644,60.39016494,KCNN3
Monoatomic Cation:Bicarbonate Symporter Activity (GO:0140410),0.052611263,0.229782644,60.39016494,SLC4A4
Dynactin Binding (GO:0034452),0.052611263,0.229782644,60.39016494,BICDL1
5'-Nucleotidase Activity (GO:0008253),0.057256012,0.229782644,53.32023276,NT5DC2
"DNA Exonuclease Activity, Producing 5'-Phosphomonoesters (GO:0016895)",0.057256012,0.229782644,53.32023276,POLD1
poly(A)-specific Ribonuclease Activity (GO:0004535),0.057256012,0.229782644,53.32023276,NOCT
"Intramolecular Oxidoreductase Activity, Transposing C=C Bonds (GO:0016863)",0.057256012,0.229782644,53.32023276,ECI1
"Oxidoreductase Activity, Acting On The CH-NH Group Of Donors, NAD Or NADP As Acceptor (GO:0016646)",0.061878221,0.229782644,47.5478141,ALDH1L1
Inhibitory Extracellular Ligand-Gated Monoatomic Ion Channel Activity (GO:0005237),0.061878221,0.229782644,47.5478141,GLRA2
Insulin-Like Growth Factor Receptor Binding (GO:0005159),0.061878221,0.229782644,47.5478141,IGF2
K63-linked Deubiquitinase Activity (GO:0061578),0.061878221,0.229782644,47.5478141,STAMBPL1
Phosphatase Activity (GO:0016791),0.062623929,0.229782644,14.12454156,DUSP10;NOCT
Alanine Transmembrane Transporter Activity (GO:0022858),0.066477997,0.229782644,42.7571585,SLC38A1
Aldehyde Dehydrogenase (NAD+) Activity (GO:0004029),0.066477997,0.229782644,42.7571585,ALDH1L1
Aldehyde Dehydrogenase [NAD(P)+] Activity (GO:0004030),0.066477997,0.229782644,42.7571585,ALDH1L1
Transaminase Activity (GO:0008483),0.066477997,0.229782644,42.7571585,GOT2
MAP Kinase Phosphatase Activity (GO:0033549),0.066477997,0.229782644,42.7571585,DUSP10
Nucleotidase Activity (GO:0008252),0.066477997,0.229782644,42.7571585,NT5DC2
RNA Polymerase III Activity (GO:0001056),0.07105545,0.240379076,38.72587138,POLR3K
Transition Metal Ion Binding (GO:0046914),0.073516039,0.24352188,6.052500457,BLM;TES;MMP16;PAPPA;CXXC4
Four-Way Junction DNA Binding (GO:0000400),0.075610686,0.24400397,35.29303732,BLM
Chemokine Binding (GO:0019956),0.080143812,0.24400397,32.33951285,ITGA4
Single-Stranded DNA Binding (GO:0003697),0.080601189,0.24400397,11.05526044,BLM;MCM5
5'-3' RNA Polymerase Activity (GO:0034062),0.084654933,0.24400397,29.77530815,POLR3K
Amino Acid:Sodium Symporter Activity (GO:0005283),0.084654933,0.24400397,29.77530815,SLC38A1
"Hydrolase Activity, Hydrolyzing N-glycosyl Compounds (GO:0016799)",0.084654933,0.24400397,29.77530815,BST1
Ligand-Gated Monoatomic Anion Channel Activity (GO:0099095),0.084654933,0.24400397,29.77530815,GLRA2
Metalloendopeptidase Activity (GO:0004222),0.087894384,0.24400397,10.13328248,MMP16;PAPPA
Alcohol Dehydrogenase (NADP+) Activity (GO:0008106),0.089144156,0.24400397,27.53125985,AKR1B1
Metalloaminopeptidase Activity (GO:0070006),0.089144156,0.24400397,27.53125985,MMP16
Actinin Binding (GO:0042805),0.093611586,0.24400397,25.55338909,MAGI1
"Oxidoreductase Activity, Acting On The Aldehyde Or Oxo Group Of Donors, NAD Or NADP As Acceptor (GO:0016620)",0.093611586,0.24400397,25.55338909,AKR1B1
DNA-directed DNA Polymerase Activity (GO:0003887),0.093611586,0.24400397,25.55338909,POLD1
DNA Polymerase Activity (GO:0034061),0.098057327,0.246298284,23.7989897,POLD1
RNA Polymerase II-specific DNA-binding Transcription Factor Binding (GO:0061629),0.101584091,0.246298284,6.315608195,TAF4B;AKR1B1;DLL1
Protein Kinase A Regulatory Subunit Binding (GO:0034237),0.102481484,0.246298284,22.23385962,AKAP1
Deubiquitinase Activity (GO:0101005),0.106144114,0.246298284,8.331526417,STAMBPL1;USP44
Alpha-Actinin Binding (GO:0051393),0.106884161,0.246298284,20.83030537,MAGI1
mRNA 3'-UTR AU-rich Region Binding (GO:0035925),0.106884161,0.246298284,20.83030537,HNRNPA0
Protein Tyrosine/Serine/Threonine Phosphatase Activity (GO:0008138),0.106884161,0.246298284,20.83030537,DUSP10
Mitogen-Activated Protein Kinase Binding (GO:0051019),0.106884161,0.246298284,20.83030537,DUSP10
"DNA-binding Transcription Repressor Activity, RNA Polymerase II-specific (GO:0001227)",0.116993947,0.264921242,5.550978635,ZEB2;SATB1;HES5
Inward Rectifier Potassium Channel Activity (GO:0005242),0.119964336,0.264921242,17.38160274,KCNN3
NF-kappaB Binding (GO:0051059),0.119964336,0.264921242,17.38160274,TAF4B
Metallopeptidase Activity (GO:0008237),0.123678089,0.267391451,7.059707441,MMP16;PAPPA
G Protein-Coupled Receptor Activity (GO:0004930),0.124469994,0.267391451,5.236088497,ADGRA1;AKR1B1;ADGRL4
Cell Adhesion Mediator Activity (GO:0098631),0.128578929,0.267391451,15.56618752,VCAM1
"RNA Endonuclease Activity, Producing 5'-Phosphomonoesters (GO:0016891)",0.128578929,0.267391451,15.56618752,RNASEH2A
Aminopeptidase Activity (GO:0004177),0.132854872,0.267391451,14.7701134,MMP16
Protein Tyrosine Kinase Activator Activity (GO:0030296),0.132854872,0.267391451,14.7701134,CD24
methyl-CpG Binding (GO:0008327),0.132854872,0.267391451,14.7701134,CXXC4
General Transcription Initiation Factor Binding (GO:0140296),0.137110046,0.269141943,14.03735619,AKR1B1
"RNA Exonuclease Activity, Producing 5'-Phosphomonoesters (GO:0016896)",0.137110046,0.269141943,14.03735619,NOCT
Ubiquitin Conjugating Enzyme Activity (GO:0061631),0.14555849,0.274989698,12.73526431,UBE2QL1
Ubiquitin-Like Protein Peptidase Activity (GO:0019783),0.14555849,0.274989698,12.73526431,USP44
Telomeric DNA Binding (GO:0042162),0.149751956,0.274989698,12.15485142,BLM
DNA Secondary Structure Binding (GO:0000217),0.149751956,0.274989698,12.15485142,BLM
3'-5'-RNA Exonuclease Activity (GO:0000175),0.153925051,0.274989698,11.61532352,NOCT
Transcription Coactivator Binding (GO:0001223),0.153925051,0.274989698,11.61532352,AKR1B1
DNA-directed 5'-3' RNA Polymerase Activity (GO:0003899),0.153925051,0.274989698,11.61532352,POLR3K
Solute:Sodium Symporter Activity (GO:0015370),0.153925051,0.274989698,11.61532352,SLC4A4
Ubiquitin-Like Protein Conjugating Enzyme Activity (GO:0061650),0.158077872,0.279270907,11.11275137,UBE2QL1
Amino Acid Binding (GO:0016597),0.162210517,0.280342089,10.64368118,GLRA2
Basal RNA Polymerase II Transcription Machinery Binding (GO:0001099),0.162210517,0.280342089,10.64368118,AKR1B1
Transmitter-Gated Monoatomic Ion Channel Activity (GO:0022824),0.178541264,0.305247967,9.046436299,GLRA2
Neutral L-amino Acid Transmembrane Transporter Activity (GO:0015175),0.182574472,0.308822778,8.705479391,SLC38A1
Kinase Activator Activity (GO:0019209),0.194556867,0.325626756,7.794244625,MOB3B
Damaged DNA Binding (GO:0003684),0.198512234,0.328785888,7.523076495,POLD1
E-box Binding (GO:0070888),0.221843899,0.363641031,6.16345781,OLIG1
Phosphoric Ester Hydrolase Activity (GO:0042578),0.225666607,0.364858453,5.97374478,DUSP10
Monoatomic Anion Channel Activity (GO:0005253),0.229470725,0.364858453,5.792783374,GLRA2
Serine-Type Endopeptidase Inhibitor Activity (GO:0004867),0.229470725,0.364858453,5.792783374,SERPINE1
Chloride Transmembrane Transporter Activity (GO:0015108),0.237023555,0.365826081,5.454963063,GLRA2
Calcium Ion Binding (GO:0005509),0.24063944,0.365826081,2.565069182,CDHR3;ASPN;THBS4
Amino Acid Transmembrane Transporter Activity (GO:0015171),0.240772444,0.365826081,5.29713271,SLC38A1
Protein Serine/Threonine Kinase Activator Activity (GO:0043539),0.240772444,0.365826081,5.29713271,IGF2
Protein Kinase Binding (GO:0019901),0.241583261,0.365826081,2.312425584,DUSP10;DCX;CD24;HNRNPA0
Metalloexopeptidase Activity (GO:0008235),0.244503099,0.366754649,5.14610322,MMP16
Nuclease Activity (GO:0004518),0.248215609,0.367942797,5.001476661,RNASEH2A
Carboxylic Acid Transmembrane Transporter Activity (GO:0046943),0.251910061,0.367942797,4.86288456,SLC38A1
Metal Ion Binding (GO:0046872),0.252237515,0.367942797,2.197669952,MTHFD2;CDHR3;ASPN;THBS4
Secondary Active Transmembrane Transporter Activity (GO:0015291),0.255586542,0.369438729,4.729985272,SLC4A4
PDZ Domain Binding (GO:0030165),0.262885936,0.376566341,4.48001881,CXXC4
L-amino Acid Transmembrane Transporter Activity (GO:0015179),0.266509021,0.378347628,4.362382466,SLC38A1
Chloride Channel Activity (GO:0005254),0.270114479,0.380072585,4.249296983,GLRA2
Methylation-Dependent Protein Binding (GO:0140034),0.284361726,0.396609776,3.837924991,SGF29
RNA Nuclease Activity (GO:0004540),0.291381772,0.402866972,3.65403968,RNASEH2A
Methylated Histone Binding (GO:0035064),0.294866192,0.404170039,3.566937408,SGF29
ATPase Binding (GO:0051117),0.301784233,0.410117035,3.401659824,AKR1B1
Ligand-Gated Monoatomic Cation Channel Activity (GO:0099094),0.308635088,0.415872704,3.24738234,KCNN3
Protein Tyrosine Phosphatase Activity (GO:0004725),0.312035522,0.416921412,3.174059444,DUSP10
Voltage-Gated Potassium Channel Activity (GO:0005249),0.325472505,0.43125107,2.903675755,KCNN3
Growth Factor Activity (GO:0008083),0.341903949,0.449278743,2.610356116,IGF2
mRNA 3'-UTR Binding (GO:0003730),0.367373933,0.478790617,2.222909001,HNRNPA0
Cysteine-Type Deubiquitinase Activity (GO:0004843),0.382794624,0.494738523,2.021243832,USP44
Transcription Coregulator Binding (GO:0001221),0.385833817,0.494738523,1.984042737,AKR1B1
Kinase Binding (GO:0019900),0.392661301,0.497422168,1.256063965,DCX;CD24;HNRNPA0
Protein Kinase Regulator Activity (GO:0019887),0.397843167,0.497422168,1.844512693,MOB3B
DNA Binding (GO:0003677),0.400183407,0.497422168,1.115970481,BLM;SATB1;POLD1;TAF4B;MCM5
DNA-binding Transcription Factor Binding (GO:0140297),0.403121931,0.497422168,1.32640662,LMO3;AKR1B1
Phosphatidylinositol Binding (GO:0035091),0.40669737,0.497422168,1.748756252,PASK
Kinase Activity (GO:0016301),0.40669737,0.497422168,1.748756252,CDC7
Endopeptidase Inhibitor Activity (GO:0004866),0.424020978,0.514651416,1.577053103,SERPINE1
Cadherin Binding (GO:0045296),0.464992359,0.555893121,0.985601103,TES;CDHR3
Receptor Ligand Activity (GO:0048018),0.464992359,0.555893121,0.985601103,IGF2;DLL1
Endopeptidase Activity (GO:0004175),0.490583896,0.582110742,0.871886821,MMP16;PAPPA
Protein Serine/Threonine Kinase Activity (GO:0004674),0.501540956,0.590703792,0.827153769,CDC7;PASK
Cysteine-Type Peptidase Activity (GO:0008234),0.508296866,0.594258836,0.96393268,USP44
Magnesium Ion Binding (GO:0000287),0.534349093,0.620156977,0.828503717,MTHFD2
Ubiquitin-Protein Transferase Activity (GO:0004842),0.602564791,0.694259433,0.501720992,UBE2QL1;KLHL13
Small GTPase Binding (GO:0031267),0.62558016,0.715591694,0.481238656,BICDL1
Guanyl-Nucleotide Exchange Factor Activity (GO:0005085),0.632938223,0.718836982,0.459856812,RAPGEF3
RNA Polymerase II Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000978),0.649461996,0.732372038,0.390245177,ZEB2;SATB1;AKR1B1;OLIG1;HES5
Transcription Regulatory Region Nucleic Acid Binding (GO:0001067),0.669282527,0.745989519,0.36531287,AKR1B1
GTPase Binding (GO:0051020),0.670921391,0.745989519,0.36144858,BICDL1
Transcription Cis-Regulatory Region Binding (GO:0000976),0.67866354,0.749357659,0.332434982,SATB1;AKR1B1
Sequence-Specific DNA Binding (GO:0043565),0.687359018,0.751260074,0.318158031,SATB1;CXXC4;HES5
Microtubule Binding (GO:0008017),0.693038907,0.751260074,0.312318373,DCX
Ubiquitin-Like Protein Transferase Activity (GO:0019787),0.694561201,0.751260074,0.309134793,KLHL13
ATP Binding (GO:0005524),0.748445164,0.802658567,0.210865461,BLM
mRNA Binding (GO:0003729),0.752176896,0.802658567,0.205002088,NOCT
Adenyl Ribonucleotide Binding (GO:0032559),0.78338959,0.830392965,0.160108051,BLM
Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000987),0.793033463,0.833700989,0.169644268,ZEB2;SATB1;AKR1B1;HES5
Tubulin Binding (GO:0015631),0.796997172,0.833700989,0.1426923,DCX
RNA Binding (GO:0003723),0.829661333,0.859274241,0.13207224,TES;NOCT;GOT2;AKAP1;HNRNPA0
Double-Stranded DNA Binding (GO:0003690),0.832253039,0.859274241,0.113663691,SATB1;HES5
Protein Homodimerization Activity (GO:0042803),0.839856827,0.861530552,0.106003404,BLM;FBLN5
RNA Polymerase II Transcription Regulatory Region Sequence-Specific DNA Binding (GO:0000977),0.858010354,0.874510553,0.099701736,ZEB2;SATB1;AKR1B1;HES5
Sequence-Specific Double-Stranded DNA Binding (GO:1990837),0.869872442,0.880953619,0.07816484,AKR1B1;HES5
GTPase Regulator Activity (GO:0030695),0.878165544,0.883723554,0.061678115,RAPGEF3
Purine Ribonucleoside Triphosphate Binding (GO:0035639),0.906182275,0.906182275,0.041537649,BLM
ECM-receptor interaction,4.65E-06,5.58E-04,193.5652597,COL1A1;COL1A2;ITGA4;ITGA11;COL6A3;THBS4
DNA replication,2.83E-05,0.001444442,276.7127563,RFC5;RNASEH2A;POLD1;MCM5
Human papillomavirus infection,3.61E-05,0.001444442,62.89827776,MAGI1;COL1A1;COL1A2;ITGA4;ITGA11;EIF4EBP1;COL6A3;THBS4;HES5
PI3K-Akt signaling pathway,6.07E-05,0.001821246,55.65823785,MAGI1;COL1A1;COL1A2;ITGA4;ITGA11;EIF4EBP1;IGF2;COL6A3;THBS4
Focal adhesion,4.67E-04,0.011215964,50.54266135,COL1A1;COL1A2;ITGA4;ITGA11;COL6A3;THBS4
AGE-RAGE signaling pathway in diabetic complications,0.001483293,0.02966587,57.18359474,COL1A1;VCAM1;COL1A2;SERPINE1
One carbon pool by folate,0.004263111,0.073081896,125.6041947,ALDH1L1;MTHFD2
Mismatch repair,0.005622726,0.08434089,102.1847637,RFC5;POLD1
Protein digestion and absorption,0.014171457,0.185431512,26.61717357,COL1A1;COL1A2;COL6A3
Homologous recombination,0.017213026,0.185431512,43.10110621,BLM;POLD1
Proteoglycans in cancer,0.018334901,0.185431512,16.67900758,COL1A1;COL1A2;LUM;IGF2
Leukocyte transendothelial migration,0.018543151,0.185431512,22.45225476,VCAM1;ITGA4;RAPGEF3
Nucleotide excision repair,0.022266164,0.205533822,34.9766995,RFC5;POLD1
Malaria,0.02499488,0.214241824,31.78953107,VCAM1;THBS4
"Phenylalanine, tyrosine and tryptophan biosynthesis",0.029045598,0.232364781,145.1819826,GOT2
Notch signaling pathway,0.03393745,0.251760114,24.53959126,DLL1;HES5
Breast cancer,0.035666016,0.251760114,14.44395145,FRAT1;DLL1;HES5
Arrhythmogenic right ventricular cardiomyopathy,0.054860703,0.365738019,15.98804109,ITGA4;ITGA11
Hypertrophic cardiomyopathy,0.07211829,0.446880678,12.33425062,ITGA4;ITGA11
Phenylalanine metabolism,0.080143812,0.446880678,32.33951285,GOT2
Dilated cardiomyopathy,0.080601189,0.446880678,11.05526044,ITGA4;ITGA11
Hematopoietic cell lineage,0.084953665,0.446880678,10.48801206,ITGA4;CD24
Amoebiasis,0.089376136,0.446880678,9.962475191,COL1A1;COL1A2
Pancreatic secretion,0.089376136,0.446880678,9.962475191,BST1;SLC4A4
HIF-1 signaling pathway,0.099951113,0.453608405,8.876431376,SERPINE1;EIF4EBP1
Arginine biosynthesis,0.102481484,0.453608405,22.23385962,GOT2
Proximal tubule bicarbonate reclamation,0.106884161,0.453608405,20.83030537,SLC4A4
Folate biosynthesis,0.119964336,0.453608405,17.38160274,AKR1B1
Cell cycle,0.123678089,0.453608405,7.059707441,CDC7;MCM5
Platelet activation,0.123678089,0.453608405,7.059707441,COL1A1;COL1A2
Relaxin signaling pathway,0.131867082,0.453608405,6.572075978,COL1A1;COL1A2
Citrate cycle (TCA cycle),0.137110046,0.453608405,14.03735619,DLST
Galactose metabolism,0.141344553,0.453608405,13.36105006,AKR1B1
RNA polymerase,0.141344553,0.453608405,13.36105006,POLR3K
Apelin signaling pathway,0.145217373,0.453608405,5.885940075,SERPINE1;CCN2
Base excision repair,0.149751956,0.453608405,12.15485142,POLD1
Fructose and mannose metabolism,0.149751956,0.453608405,12.15485142,AKR1B1
Ubiquitin mediated proteolysis,0.150295033,0.453608405,5.65456582,UBE2QL1;KLHL13
Pentose and glucuronate interconversions,0.153925051,0.453608405,11.61532352,AKR1B1
Nicotinate and nicotinamide metabolism,0.158077872,0.453608405,11.11275137,BST1
Tyrosine metabolism,0.162210517,0.453608405,10.64368118,GOT2
Cell adhesion molecules,0.164003426,0.453608405,5.09649535,VCAM1;ITGA4
African trypanosomiasis,0.166323082,0.453608405,10.20506582,VCAM1
"Alanine, aspartate and glutamate metabolism",0.166323082,0.453608405,10.20506582,GOT2
Cellular senescence,0.177925675,0.45837368,4.612112739,SERPINE1;EIF4EBP1
Tryptophan metabolism,0.186588079,0.45837368,8.38412801,DLST
Hippo signaling pathway,0.190254454,0.45837368,4.238881301,SERPINE1;CCN2
Fat digestion and absorption,0.19058218,0.45837368,8.080844797,GOT2
Fatty acid degradation,0.19058218,0.45837368,8.080844797,ECI1
Wnt signaling pathway,0.195574114,0.45837368,4.09156271,FRAT1;CXXC4
Basal transcription factors,0.198512234,0.45837368,7.523076495,TAF4B
Hepatocellular carcinoma,0.199131234,0.45837368,3.997211746,FRAT1;IGF2
Proteasome,0.202448375,0.45837368,7.266207924,PSMC3
Intestinal immune network for IgA production,0.210263346,0.467148244,6.79135291,ITGA4
Arginine and proline metabolism,0.218002514,0.467148244,6.362519703,GOT2
Cysteine and methionine metabolism,0.218002514,0.467148244,6.362519703,GOT2
Fanconi anemia pathway,0.233256345,0.49106599,5.620024608,BLM
Glutathione metabolism,0.244503099,0.502971821,5.14610322,CHAC1
Glycerolipid metabolism,0.259245138,0.502971821,4.602461627,AKR1B1
Diabetic cardiomyopathy,0.262262745,0.502971821,2.733000059,COL1A1;COL1A2
Pathways in cancer,0.262992141,0.502971821,2.089535558,FRAT1;IGF2;DLL1;HES5
Cytosolic DNA-sensing pathway,0.266509021,0.502971821,4.362382466,POLR3K
Lysine degradation,0.266509021,0.502971821,4.362382466,DLST
GnRH secretion,0.270114479,0.502971821,4.249296983,KCNN3
Rap1 signaling pathway,0.274976693,0.502971821,2.546705898,MAGI1;RAPGEF3
Acute myeloid leukemia,0.280825934,0.502971821,3.935039328,EIF4EBP1
Long-term potentiation,0.280825934,0.502971821,3.935039328,RAPGEF3
Regulation of actin cytoskeleton,0.289496448,0.510876085,2.353685067,ITGA4;ITGA11
p53 signaling pathway,0.301784233,0.524842145,3.401659824,SERPINE1
Leishmaniasis,0.315419402,0.540718974,3.103129621,ITGA4
Chemical carcinogenesis,0.327415549,0.553378393,1.930069139,EIF4EBP1;DLL1
Complement and coagulation cascades,0.341903949,0.559690342,2.610356116,SERPINE1
ErbB signaling pathway,0.341903949,0.559690342,2.610356116,EIF4EBP1
Insulin secretion,0.345142377,0.559690342,2.556857502,KCNN3
GABAergic synapse,0.354763322,0.565167013,2.405498549,SLC38A1
Bile secretion,0.357939108,0.565167013,2.357897086,SLC4A4
Th1 and Th2 cell differentiation,0.364244339,0.565190666,2.266651258,DLL1
Salivary secretion,0.367373933,0.565190666,2.222909001,BST1
Circadian entrainment,0.379740546,0.574191936,2.059439097,RASD1
Choline metabolism in cancer,0.382794624,0.574191936,2.021243832,EIF4EBP1
Chagas disease,0.394862801,0.577848001,1.878067176,SERPINE1
Longevity regulating pathway,0.394862801,0.577848001,1.878067176,EIF4EBP1
NF-kappa B signaling pathway,0.400809004,0.579482898,1.811794309,VCAM1
"Parathyroid hormone synthesis, secretion and action",0.40669737,0.580996243,1.748756252,MMP16
MAPK signaling pathway,0.423571579,0.585932053,1.201885876,DUSP10;IGF2
TNF signaling pathway,0.424020978,0.585932053,1.577053103,VCAM1
Serotonergic synapse,0.426859163,0.585932053,1.550740955,RAPGEF3
Glutamatergic synapse,0.429683505,0.585932053,1.525033707,SLC38A1
Huntington disease,0.443662403,0.593769193,1.09149707,PSMC3;TAF4B
AMPK signaling pathway,0.446342566,0.593769193,1.382510929,EIF4EBP1
MicroRNAs in cancer,0.450274972,0.593769193,1.057493951,ZEB2;MMP16
Systemic lupus erythematosus,0.485912436,0.626504763,1.09763781,H3C6
Yersinia infection,0.490972336,0.626504763,1.06586491,ITGA4
Insulin signaling pathway,0.490972336,0.626504763,1.06586491,EIF4EBP1
Fluid shear stress and atherosclerosis,0.495982937,0.626504763,1.035319634,VCAM1
Spinocerebellar ataxia,0.50585814,0.628645992,0.977669546,PSMC3
Phospholipase D signaling pathway,0.51793321,0.628645992,0.911493932,RAPGEF3
Gastric cancer,0.520312941,0.628645992,0.898981531,FRAT1
Adrenergic signaling in cardiomyocytes,0.522681044,0.628645992,0.886696711,RAPGEF3
Phagosome,0.52738259,0.628645992,0.862788483,THBS4
mTOR signaling pathway,0.532038294,0.628645992,0.839728134,EIF4EBP1
Cushing syndrome,0.534349093,0.628645992,0.828503717,RASD1
Alzheimer disease,0.542379723,0.631898706,0.67843419,FRAT1;PSMC3
Tight junction,0.56553883,0.652544804,0.690225376,MAGI1
Alcoholism,0.60064346,0.679973728,0.560089996,H3C6
RNA transport,0.60064346,0.679973728,0.560089996,EIF4EBP1
Neutrophil extracellular trap formation,0.606540127,0.680231918,0.540507364,H3C6
Transcriptional misregulation in cancer,0.612350603,0.680389558,0.521793355,H3C6
Epstein-Barr virus infection,0.631112237,0.694802462,0.465087451,PSMC3
Lipid and atherosclerosis,0.654164463,0.709056719,0.40252038,VCAM1
cAMP signaling pathway,0.655877465,0.709056719,0.398159119,RAPGEF3
Human cytomegalovirus infection,0.670921391,0.718074235,0.36144858,EIF4EBP1
Pathways of neurodegeneration,0.679789078,0.718074235,0.330297029,FRAT1;PSMC3
Ras signaling pathway,0.682170523,0.718074235,0.335773548,IGF2
Shigellosis,0.7035393,0.732341266,0.290848777,H3C6
Parkinson disease,0.70792989,0.732341266,0.282203707,PSMC3
Prion disease,0.740814046,0.759809278,0.223207649,PSMC3
Neuroactive ligand-receptor interaction,0.815376738,0.829196682,0.121064353,GLRA2
Amyotrophic lateral sclerosis,0.835433904,0.842454357,0.099775389,PSMC3
Herpes simplex virus 1 infection,0.916019031,0.916019031,0.035308147,EIF4EBP1
DNA Replication (GO:0006260),2.94E-05,0.023142119,163.6262543,RFC5;BLM;RNASEH2A;POLD1;MCM5
Regulation Of Epithelial Cell Differentiation (GO:0030856),8.82E-05,0.034724869,390.8478036,PRKX;CD24;DLL1
Astrocyte Differentiation (GO:0048708),2.35E-04,0.046311077,1154.460936,DLL1;HES5
Regulation Of Superoxide Metabolic Process (GO:0090322),2.35E-04,0.046311077,1154.460936,BST1;FBLN5
DNA-templated DNA Replication (GO:0006261),3.67E-04,0.049414595,102.7218462,RFC5;BLM;POLD1;MCM5
Regulation Of Cell Differentiation (GO:0045595),3.77E-04,0.049414595,54.20807866,IGF2;AKR1B1;CCN2;CD24;DLL1;HES5
Positive Regulation Of Cell Differentiation (GO:0045597),4.87E-04,0.054748376,41.72070613,COL1A1;LMO3;ZC4H2;NOCT;TMEM119;AKR1B1;CCN2
Skin Morphogenesis (GO:0043589),6.53E-04,0.064216395,506.6767474,COL1A1;COL1A2
Regulation Of Cell Division (GO:0051302),7.41E-04,0.064760788,76.96490528,BLM;SGF29;KLHL13;DLL1
Collagen Fibril Organization (GO:0030199),0.001140121,0.089727529,108.9911087,COL1A1;COL1A2;LUM
Double-Strand Break Repair Via Break-Induced Replication (GO:0000727),0.001269995,0.09086238,307.0863163,CDC7;MCM5
Positive Regulation Of Vascular Endothelial Cell Proliferation (GO:1905564),0.001519135,0.09962991,268.9404392,ITGA4;IGF2
Extracellular Matrix Organization (GO:0030198),0.001750245,0.102370714,39.38011076,COL1A1;COL1A2;MMP16;LUM;HMCN1
Dicarboxylic Acid Metabolic Process (GO:0043648),0.001892224,0.102370714,83.64450284,MTHFD2;GOT2;DLST
Cell-Matrix Adhesion (GO:0007160),0.00203512,0.102370714,49.72076124,VCAM1;ITGA4;ITGA11;FBLN5
2-Oxoglutarate Metabolic Process (GO:0006103),0.002081234,0.102370714,213.2233597,GOT2;DLST
Negative Regulation Of Protein Processing (GO:0010955),0.002393775,0.110817679,192.3522519,SERPINE1;CHAC1
Dicarboxylic Acid Catabolic Process (GO:0043649),0.002727031,0.115456512,174.7463246,ALDH1L1;GOT2
Chordate Embryonic Development (GO:0043009),0.003040292,0.115456512,64.86286634,COL1A1;IGF2;HES5
Leukocyte Tethering Or Rolling (GO:0050901),0.003080796,0.115456512,159.7193234,VCAM1;ITGA4
Regulation Of DNA-templated DNA Replication (GO:0090329),0.003080796,0.115456512,159.7193234,BLM;MCM5
Regulation Of Vascular Endothelial Cell Proliferation (GO:1905562),0.003454867,0.118216534,146.7620806,ITGA4;IGF2
Response To Ethanol (GO:0045471),0.003454867,0.118216534,146.7620806,GLRA2;GOT2
Positive Regulation Of Activated T Cell Proliferation (GO:0042104),0.003849039,0.121061791,135.4892689,IGF2;CD24
Leukocyte Adhesion To Vascular Endothelial Cell (GO:0061756),0.003849039,0.121061791,135.4892689,VCAM1;ITGA4
Positive Regulation Of T Cell Proliferation (GO:0042102),0.0039995,0.121061791,55.79707861,VCAM1;IGF2;CD24
Skin Development (GO:0043588),0.004540562,0.132348978,51.99097274,COL1A1;COL1A2;DLL1
Response To Molecule Of Bacterial Origin (GO:0002237),0.004730265,0.132954239,50.81218251,NOCT;CD24;HNRNPA0
Regulation Of Protein Export From Nucleus (GO:0046825),0.005150152,0.13976448,109.1175725,FRAT1;RAPGEF3
Negative Regulation Of Neuron Differentiation (GO:0045665),0.005622726,0.14274469,102.1847637,DLL1;HES5
Glial Cell Development (GO:0021782),0.005622726,0.14274469,102.1847637,DLL1;HES5
Skeletal System Development (GO:0001501),0.006219325,0.152956535,29.45485362,COL1A1;COL1A2;MMP16;HES5
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),0.006420899,0.153128707,42.71507268,ITGA4;IGF2;THBS4
Regulation Of Glycogen Biosynthetic Process (GO:0005979),0.006624998,0.153349229,90.3361026,IGF2;PASK
Regulation Of Neuron Differentiation (GO:0045664),0.006892716,0.154987639,41.00266766,ZC4H2;DLL1;HES5
Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),0.00842957,0.183342882,36.45462432,COL1A1;FRAT1;ZEB2
Negative Regulation Of Angiogenesis (GO:0016525),0.008703665,0.183342882,35.77231023,TNMD;SERPINE1;THBS4
Heterotypic Cell-Cell Adhesion (GO:0034113),0.008852642,0.183342882,72.49221144,VCAM1;ITGA4
Positive Regulation Of Cell Population Proliferation (GO:0008284),0.009628425,0.188785889,14.57589032,BST1;IGF2;TMEM119;AKR1B1;CDC7;DLL1;HES5
Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),0.009852117,0.188785889,33.22927978,BST1;IGF2;THBS4
Glutamine Family Amino Acid Metabolic Process (GO:0009064),0.010074978,0.188785889,65.63943969,SLC38A1;GOT2
Leukocyte Cell-Cell Adhesion (GO:0007159),0.010074978,0.188785889,65.63943969,VCAM1;ITGA4
Regulation Of Activated T Cell Proliferation (GO:0046006),0.011367668,0.205364674,59.78636557,IGF2;CD24
Cellular Response To Amyloid-Beta (GO:1904646),0.012039937,0.205364674,57.17186348,VCAM1;ITGA4
Glial Cell Differentiation (GO:0010001),0.012039937,0.205364674,57.17186348,BCAN;HES5
Cellular Response To Amino Acid Stimulus (GO:0071230),0.012729249,0.205364674,54.73825293,GLRA2;STAMBPL1
DNA Metabolic Process (GO:0006259),0.013703547,0.205364674,15.98987113,RFC5;BLM;RNASEH2A;POLD1;MCM5
DNA Repair (GO:0006281),0.014274309,0.205364674,15.66925149,RFC5;BLM;RNASEH2A;USP44;POLD1
Odontogenesis (GO:0042476),0.015653339,0.205364674,46.49786958,COL1A1;COL1A2
Notch Signaling Pathway (GO:0007219),0.016425191,0.205364674,44.74778866,DLL1;HES5
Positive Regulation Of Wnt Signaling Pathway (GO:0030177),0.016473654,0.205364674,24.21516462,COL1A1;FRAT1;ZEB2
Extracellular Structure Organization (GO:0043062),0.016473654,0.205364674,24.21516462,COL1A1;COL1A2;MMP16
External Encapsulating Structure Organization (GO:0045229),0.01687654,0.205364674,23.84648518,COL1A1;COL1A2;MMP16
DNA Duplex Unwinding (GO:0032508),0.017213026,0.205364674,43.10110621,BLM;MCM5
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),0.017284927,0.205364674,23.48610438,BLM;CDC7;MCM5
Positive Regulation Of Cellular Component Organization (GO:0051130),0.018118227,0.205364674,22.78922929,AKR1B1;DLL1;RAPGEF3
Regulation Of Angiogenesis (GO:0045765),0.018334901,0.205364674,16.67900758,TNMD;SERPINE1;RAPGEF3;THBS4
DNA-templated DNA Replication Maintenance Of Fidelity (GO:0045005),0.018835962,0.205364674,40.08518332,BLM;POLD1
Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),0.018835962,0.205364674,40.08518332,ITGA4;SERPINE1
Response To Amyloid-Beta (GO:1904645),0.018835962,0.205364674,40.08518332,VCAM1;ITGA4
Positive Regulation Of Stress Fiber Assembly (GO:0051496),0.018835962,0.205364674,40.08518332,CCN2;RAPGEF3
Negative Regulation Of Cell Differentiation (GO:0045596),0.018927069,0.205364674,16.38174762,NOCT;IGF2;DLL1;HES5
Nervous System Development (GO:0007399),0.019738128,0.205364674,11.67549072,ZEB2;C3ORF70;ZC4H2;DCX;CHAC1;HES5
Positive Regulation Of Angiogenesis (GO:0045766),0.020750668,0.205364674,20.87320759,SERPINE1;DLL1;RAPGEF3
Regulation Of Nervous System Development (GO:0051960),0.02138599,0.205364674,36.15264774,DLL1;HES5
Epithelial Cell Migration (GO:0010631),0.02138599,0.205364674,36.15264774,ZEB2;PRKX
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),0.022141595,0.205364674,20.00330253,IGF2;AKR1B1;PASK
Protein Monoubiquitination (GO:0006513),0.022266164,0.205364674,34.9766995,ZC4H2;KBTBD8
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),0.023161145,0.205364674,33.86022788,DUSP10;LMO3
Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.024070771,0.205364674,32.79909572,VCAM1;HMCN1
Negative Regulation Of Glycogen Biosynthetic Process (GO:0045719),0.024263309,0.205364674,190.7125852,PASK
Regulation Of Glucagon Secretion (GO:0070092),0.024263309,0.205364674,190.7125852,PASK
Regulation Of Glycogen (Starch) Synthase Activity (GO:2000465),0.024263309,0.205364674,190.7125852,IGF2
Regulation Of Mitotic Spindle Checkpoint (GO:1903504),0.024263309,0.205364674,190.7125852,USP44
Aspartate Metabolic Process (GO:0006531),0.024263309,0.205364674,190.7125852,GOT2
"Nucleotide-Excision Repair, DNA Gap Filling (GO:0006297)",0.024263309,0.205364674,190.7125852,POLD1
Regulation Of pro-B Cell Differentiation (GO:2000973),0.024263309,0.205364674,190.7125852,HES5
Regulation Of Tooth Mineralization (GO:0070170),0.024263309,0.205364674,190.7125852,ASPN
Renal Filtration Cell Differentiation (GO:0061318),0.024263309,0.205364674,190.7125852,CD24
Gamma-Aminobutyric Acid Metabolic Process (GO:0009448),0.024263309,0.205364674,190.7125852,SLC38A1
Glomerular Epithelial Cell Differentiation (GO:0072311),0.024263309,0.205364674,190.7125852,CD24
Positive Regulation Of Nuclear Cell Cycle DNA Replication (GO:0010571),0.024263309,0.205364674,190.7125852,CDC7
Positive Regulation Of Osteoblast Proliferation (GO:0033690),0.024263309,0.205364674,190.7125852,TMEM119
Positive Regulation Of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035360),0.024263309,0.205364674,190.7125852,LMO3
Heterocycle Catabolic Process (GO:0046700),0.024263309,0.205364674,190.7125852,GOT2
Kidney Morphogenesis (GO:0060993),0.024263309,0.205364674,190.7125852,PRKX
Negative Regulation Of Astrocyte Differentiation (GO:0048712),0.024263309,0.205364674,190.7125852,HES5
Positive Regulation Of Fat Cell Differentiation (GO:0045600),0.02499488,0.205364674,31.78953107,LMO3;NOCT
Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),0.02593331,0.205364674,30.82808827,CCN2;RAPGEF3
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),0.026094453,0.205364674,17.92796349,IGF2;THBS4;HES5
Positive Regulation Of Cellular Process (GO:0048522),0.026750926,0.205364674,9.165667854,BST1;IGF2;AKR1B1;CDC7;CCN2;DLL1;HES5
Cell Cycle G1/S Phase Transition (GO:0044843),0.026885902,0.205364674,29.911614,EIF4EBP1;CDC7
Regulation Of Cell Development (GO:0060284),0.026885902,0.205364674,29.911614,DLL1;HES5
Positive Regulation Of Phosphorylation (GO:0042327),0.02696652,0.205364674,13.32625486,IGF2;TMEM119;AKR1B1;MOB3B
Positive Regulation Of Developmental Process (GO:0051094),0.027715714,0.205364674,13.1083476,TMEM119;AKR1B1;CCN2;RAPGEF3
Cellular Response To Alcohol (GO:0097306),0.027852499,0.205364674,29.03721725,BLM;GLRA2
mRNA Stabilization (GO:0048255),0.027852499,0.205364674,29.03721725,NOCT;HNRNPA0
Negative Regulation Of Glycogen Metabolic Process (GO:0070874),0.029045598,0.205364674,145.1819826,PASK
Regulation Of Glial Cell Apoptotic Process (GO:0034350),0.029045598,0.205364674,145.1819826,DLL1
Regulation Of Glucocorticoid Receptor Signaling Pathway (GO:2000322),0.029045598,0.205364674,145.1819826,LMO3
Negative Regulation Of Oligodendrocyte Differentiation (GO:0048715),0.029045598,0.205364674,145.1819826,HES5
Negative Regulation Of p38MAPK Cascade (GO:1903753),0.029045598,0.205364674,145.1819826,DUSP10
Negative Regulation Of Plasminogen Activation (GO:0010757),0.029045598,0.205364674,145.1819826,SERPINE1
Regulation Of Respiratory Gaseous Exchange (GO:0043576),0.029045598,0.205364674,145.1819826,PASK
Elastic Fiber Assembly (GO:0048251),0.029045598,0.205364674,145.1819826,FBLN5
Glandular Epithelial Cell Development (GO:0002068),0.029045598,0.205364674,145.1819826,DLL1
Type B Pancreatic Cell Development (GO:0003323),0.029045598,0.205364674,145.1819826,DLL1
Regulation Of Mitotic Nuclear Division (GO:0007088),0.030834748,0.205364674,26.64098592,USP44;IGF2
Nucleotide-Excision Repair (GO:0006289),0.030834748,0.205364674,26.64098592,USP44;POLD1
Cellular Response To Peptide (GO:1901653),0.030834748,0.205364674,26.64098592,VCAM1;ITGA4
Muscle Organ Development (GO:0007517),0.032890086,0.205364674,25.21050369,ITGA11;COL6A3
Negative Regulation Of Glial Cell Apoptotic Process (GO:0034351),0.033804687,0.205364674,115.7918426,DLL1
Negative Regulation Of Muscle Cell Differentiation (GO:0051148),0.033804687,0.205364674,115.7918426,IGF2
Neuron Fate Specification (GO:0048665),0.033804687,0.205364674,115.7918426,DLL1
Axon Ensheathment In Central Nervous System (GO:0032291),0.033804687,0.205364674,115.7918426,HES5
Nonribosomal Peptide Biosynthetic Process (GO:0019184),0.033804687,0.205364674,115.7918426,CHAC1
Peptidyl-Tyrosine Dephosphorylation Involved In Inactivation Of Protein Kinase Activity (GO:1990264),0.033804687,0.205364674,115.7918426,DUSP10
Regulation Of Vascular Wound Healing (GO:0061043),0.033804687,0.205364674,115.7918426,SERPINE1
Positive Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033145),0.033804687,0.205364674,115.7918426,LMO3
Positive Regulation Of Melanin Biosynthetic Process (GO:0048023),0.033804687,0.205364674,115.7918426,ZEB2
Tooth Mineralization (GO:0034505),0.033804687,0.205364674,115.7918426,COL1A1
Positive Regulation Of Secondary Metabolite Biosynthetic Process (GO:1900378),0.033804687,0.205364674,115.7918426,ZEB2
Proximal/Distal Pattern Formation (GO:0009954),0.033804687,0.205364674,115.7918426,DLL1
Myoblast Migration (GO:0051451),0.033804687,0.205364674,115.7918426,THBS4
Regulation Of Multicellular Organismal Development (GO:2000026),0.03393745,0.205364674,24.53959126,SGF29;CD24
Regulation Of Cell Population Proliferation (GO:0042127),0.034356302,0.205364674,7.567733367,BST1;TES;CDCA7;IGF2;AKR1B1;CDC7;DLL1;HES5
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),0.038254707,0.205364674,22.11437109,EIF4EBP1;CDC7
Negative Regulation Of Glial Cell Differentiation (GO:0045686),0.038540687,0.205364674,95.40343353,HES5
Negative Regulation Of Mitotic Nuclear Division (GO:0045839),0.038540687,0.205364674,95.40343353,USP44
Negative Regulation Of Ubiquitin Protein Ligase Activity (GO:1904667),0.038540687,0.205364674,95.40343353,USP44
Regulation Of Mitotic Sister Chromatid Segregation (GO:0033047),0.038540687,0.205364674,95.40343353,USP44
Regulation Of Nuclear Cell Cycle DNA Replication (GO:0033262),0.038540687,0.205364674,95.40343353,CDC7
Cellular Response To Hydroxyurea (GO:0072711),0.038540687,0.205364674,95.40343353,BLM
Collagen-Activated Signaling Pathway (GO:0038065),0.038540687,0.205364674,95.40343353,ITGA11
Embryonic Placenta Development (GO:0001892),0.038540687,0.205364674,95.40343353,IGF2
Endochondral Ossification (GO:0001958),0.038540687,0.205364674,95.40343353,TMEM119
Establishment Of Protein Localization To Chromatin (GO:0071169),0.038540687,0.205364674,95.40343353,SGF29
succinyl-CoA Metabolic Process (GO:0006104),0.038540687,0.205364674,95.40343353,DLST
Tetrahydrofolate Interconversion (GO:0035999),0.038540687,0.205364674,95.40343353,MTHFD2
Glutamine Transport (GO:0006868),0.038540687,0.205364674,95.40343353,SLC38A1
Type B Pancreatic Cell Differentiation (GO:0003309),0.038540687,0.205364674,95.40343353,DLL1
Cellular Response To Organic Cyclic Compound (GO:0071407),0.038781254,0.205364674,13.60515591,BLM;AKR1B1;RAPGEF3
Positive Regulation Of DNA-templated Transcription (GO:0045893),0.040682614,0.205364674,6.135107709,COL1A1;BLM;ZEB2;PSMC3;LMO3;IGF2;AKR1B1;OLIG1;SGF29;DLL1;HES5
Regulation Of Protein Phosphorylation (GO:0001932),0.041402786,0.205364674,10.19726743,BST1;IGF2;TMEM119;MOB3B
Regulation Of Neurogenesis (GO:0050767),0.042769419,0.205364674,20.04002363,DLL1;HES5
Regulation Of Cellular Response To Oxidative Stress (GO:1900407),0.04325371,0.205364674,80.51615206,FBLN5
Negative Regulation Of Protein Maturation (GO:1903318),0.04325371,0.205364674,80.51615206,CHAC1
Amine Metabolic Process (GO:0009308),0.04325371,0.205364674,80.51615206,VCAM1
Biomineral Tissue Development (GO:0031214),0.04325371,0.205364674,80.51615206,COL1A1
Nucleobase-Containing Compound Biosynthetic Process (GO:0034654),0.04325371,0.205364674,80.51615206,POLD1
Regulation Of Postsynaptic Neurotransmitter Receptor Activity (GO:0098962),0.04325371,0.205364674,80.51615206,NPTXR
Cell Differentiation In Spinal Cord (GO:0021515),0.04325371,0.205364674,80.51615206,ZC4H2
Response To Hydroxyurea (GO:0072710),0.04325371,0.205364674,80.51615206,BLM
Positive Regulation Of Skeletal Muscle Tissue Development (GO:0048643),0.04325371,0.205364674,80.51615206,DLL1
Muscle Cell Migration (GO:0014812),0.04325371,0.205364674,80.51615206,THBS4
Negative Regulation Of Bone Resorption (GO:0045779),0.04325371,0.205364674,80.51615206,TMEM119
Negative Regulation Of Cell Adhesion Mediated By Integrin (GO:0033629),0.04325371,0.205364674,80.51615206,SERPINE1
Regulation Of Cellular Extravasation (GO:0002691),0.04325371,0.205364674,80.51615206,BST1
Response To Lipopolysaccharide (GO:0032496),0.043368086,0.205364674,12.54323257,NOCT;SERPINE1;HNRNPA0
B Cell Differentiation (GO:0030183),0.043927872,0.205364674,19.56805291,VCAM1;ITGA4
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.046279519,0.205364674,18.67370954,DUSP10;TNMD
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),0.046279519,0.205364674,18.67370954,SERPINE1;AKR1B1
Regulation Of Notch Signaling Pathway (GO:0008593),0.046279519,0.205364674,18.67370954,CHAC1;DLL1
Regulation Of Actin Filament-Based Process (GO:0032970),0.046279519,0.205364674,18.67370954,BST1;RAPGEF3
Negative Regulation Of Hemostasis (GO:1900047),0.047943866,0.205364674,69.22044886,SERPINE1
Regulation Of Gene Expression By Genomic Imprinting (GO:0006349),0.047943866,0.205364674,69.22044886,IGF2
Rap Protein Signal Transduction (GO:0032486),0.047943866,0.205364674,69.22044886,RAPGEF3
Regulation Of Melanin Biosynthetic Process (GO:0048021),0.047943866,0.205364674,69.22044886,ZEB2
Regulation Of Mitotic Sister Chromatid Separation (GO:0010965),0.047943866,0.205364674,69.22044886,USP44
Basement Membrane Organization (GO:0071711),0.047943866,0.205364674,69.22044886,HMCN1
Regulation Of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035358),0.047943866,0.205364674,69.22044886,LMO3
Cellular Response To Leucine (GO:0071233),0.047943866,0.205364674,69.22044886,STAMBPL1
Positive Regulation Of DNA-templated DNA Replication (GO:2000105),0.047943866,0.205364674,69.22044886,CDC7
Response To Leucine (GO:0043201),0.047943866,0.205364674,69.22044886,STAMBPL1
Fatty Acid Homeostasis (GO:0055089),0.047943866,0.205364674,69.22044886,POLD1
Histone H3-K14 Acetylation (GO:0044154),0.047943866,0.205364674,69.22044886,SGF29
Cholesterol Homeostasis (GO:0042632),0.04867657,0.205364674,17.8402857,TMEM97;CD24
Sterol Homeostasis (GO:0055092),0.049891779,0.205364674,17.44464085,TMEM97;CD24
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),0.05111793,0.205364674,17.06217707,BST1;VCAM1
Regulation Of Fat Cell Differentiation (GO:0045598),0.052354889,0.205364674,16.69229412,LMO3;NOCT
Regulation Of Stress Fiber Assembly (GO:0051492),0.052354889,0.205364674,16.69229412,CCN2;RAPGEF3
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),0.05257136,0.205364674,10.86114076,VCAM1;CDHR3;HMCN1
Negative Regulation Of Fibrinolysis (GO:0051918),0.052611263,0.205364674,60.39016494,SERPINE1
Negative Regulation Of Myotube Differentiation (GO:0010832),0.052611263,0.205364674,60.39016494,TMEM119
Aspartate Family Amino Acid Catabolic Process (GO:0009068),0.052611263,0.205364674,60.39016494,GOT2
Neurotransmitter Uptake (GO:0001504),0.052611263,0.205364674,60.39016494,SLC38A1
Organic Cyclic Compound Catabolic Process (GO:1901361),0.052611263,0.205364674,60.39016494,GOT2
Podocyte Differentiation (GO:0072112),0.052611263,0.205364674,60.39016494,CD24
Central Nervous System Myelination (GO:0022010),0.052611263,0.205364674,60.39016494,HES5
Response To X-ray (GO:0010165),0.052611263,0.205364674,60.39016494,BLM
Positive Regulation Of Coagulation (GO:0050820),0.052611263,0.205364674,60.39016494,SERPINE1
Epithelial Cell-Cell Adhesion (GO:0090136),0.052611263,0.205364674,60.39016494,THBS4
Positive Regulation Of Hemostasis (GO:1900048),0.052611263,0.205364674,60.39016494,SERPINE1
Tetrahydrofolate Metabolic Process (GO:0046653),0.052611263,0.205364674,60.39016494,MTHFD2
Regulation Of Astrocyte Differentiation (GO:0048710),0.052611263,0.205364674,60.39016494,HES5
Negative Regulation Of Bone Remodeling (GO:0046851),0.052611263,0.205364674,60.39016494,TMEM119
Negative Regulation Of Cell Division (GO:0051782),0.052611263,0.205364674,60.39016494,BLM
Wnt Signaling Pathway (GO:0016055),0.053602524,0.205364674,16.33442651,FRAT1;CD24
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),0.054064749,0.205364674,10.63095675,ZEB2;IGF2;PASK
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),0.054860703,0.205364674,15.98804109,TNMD;THBS4
Negative Regulation Of Stem Cell Differentiation (GO:2000737),0.057256012,0.205364674,53.32023276,HES5
Aspartate Family Amino Acid Metabolic Process (GO:0009066),0.057256012,0.205364674,53.32023276,GOT2
"Base-Excision Repair, Gap-Filling (GO:0006287)",0.057256012,0.205364674,53.32023276,POLD1
Positive Regulation Of DNA-directed DNA Polymerase Activity (GO:1900264),0.057256012,0.205364674,53.32023276,RFC5
Secretion (GO:0046903),0.057256012,0.205364674,53.32023276,FBLN5
Endochondral Bone Morphogenesis (GO:0060350),0.057256012,0.205364674,53.32023276,TMEM119
Sodium Ion Export Across Plasma Membrane (GO:0036376),0.057256012,0.205364674,53.32023276,SLC4A4
Spinal Cord Development (GO:0021510),0.057256012,0.205364674,53.32023276,DLL1
Positive Regulation Of Insulin Receptor Signaling Pathway (GO:0046628),0.057256012,0.205364674,53.32023276,IGF2
Fibrinolysis (GO:0042730),0.057256012,0.205364674,53.32023276,SERPINE1
Folic Acid Metabolic Process (GO:0046655),0.057256012,0.205364674,53.32023276,MTHFD2
Positive Regulation Of Protein Export From Nucleus (GO:0046827),0.057256012,0.205364674,53.32023276,RAPGEF3
Regulation Of DNA-directed DNA Polymerase Activity (GO:1900262),0.057256012,0.205364674,53.32023276,RFC5
Regulation Of DNA-templated DNA Replication Initiation (GO:0030174),0.057256012,0.205364674,53.32023276,MCM5
Negative Regulation By Host Of Viral Process (GO:0044793),0.057256012,0.205364674,53.32023276,PSMC3
Negative Regulation By Host Of Viral Transcription (GO:0043922),0.057256012,0.205364674,53.32023276,PSMC3
Negative Regulation Of JUN Kinase Activity (GO:0043508),0.057256012,0.205364674,53.32023276,DUSP10
Negative Regulation Of Coagulation (GO:0050819),0.057256012,0.205364674,53.32023276,SERPINE1
Positive Regulation Of Endocytosis (GO:0045807),0.057408168,0.205364674,15.32773247,SERPINE1;DLL1
Negative Regulation Of Cellular Component Organization (GO:0051129),0.057408168,0.205364674,15.32773247,AKR1B1;RAPGEF3
Regulation Of Intracellular Signal Transduction (GO:1902531),0.058316194,0.20766898,8.093288184,BST1;CD24;MOB3B;RAPGEF3
Negative Regulation Of Myoblast Differentiation (GO:0045662),0.061878221,0.210814544,47.5478141,DLL1
Regulation Of Leukocyte Migration (GO:0002685),0.061878221,0.210814544,47.5478141,BST1
Negative Regulation Of Translational Initiation (GO:0045947),0.061878221,0.210814544,47.5478141,EIF4EBP1
Cellular Modified Amino Acid Catabolic Process (GO:0042219),0.061878221,0.210814544,47.5478141,GOT2
Positive Regulation Of Cellular Response To Insulin Stimulus (GO:1900078),0.061878221,0.210814544,47.5478141,IGF2
Positive Regulation Of Glycogen Biosynthetic Process (GO:0045725),0.061878221,0.210814544,47.5478141,IGF2
Substrate-Dependent Cell Migration (GO:0006929),0.061878221,0.210814544,47.5478141,ITGA11
Glutamine Metabolic Process (GO:0006541),0.061878221,0.210814544,47.5478141,SLC38A1
Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),0.061878221,0.210814544,47.5478141,CD24
Mature B Cell Differentiation Involved In Immune Response (GO:0002313),0.061878221,0.210814544,47.5478141,DLL1
Epigenetic Regulation Of Gene Expression (GO:0040029),0.062623929,0.211523744,14.12454156,IGF2;SGF29
Vascular Transport (GO:0010232),0.062623929,0.211523744,14.12454156,SLC38A1;SLC4A4
Regulation Of Osteoblast Differentiation (GO:0045667),0.065290203,0.216807551,13.57538466,NOCT;TMEM119
Epidermis Development (GO:0008544),0.065290203,0.216807551,13.57538466,CCN2;DLL1
Transport Across Blood-Brain Barrier (GO:0150104),0.065290203,0.216807551,13.57538466,SLC38A1;SLC4A4
Integrin-Mediated Signaling Pathway (GO:0007229),0.065290203,0.216807551,13.57538466,ITGA4;ITGA11
Negative Regulation Of Smooth Muscle Cell Migration (GO:0014912),0.066477997,0.217087901,42.7571585,SERPINE1
Regulation Of Phosphate Metabolic Process (GO:0019220),0.066477997,0.217087901,42.7571585,CD24
Positive Regulation Of Glycogen Metabolic Process (GO:0070875),0.066477997,0.217087901,42.7571585,IGF2
Establishment Of Protein Localization To Chromosome (GO:0070199),0.066477997,0.217087901,42.7571585,SGF29
Regulation Of Signal Transduction (GO:0009966),0.0692462,0.221907299,8.747826359,BST1;CD24;DLL1
Supramolecular Fiber Organization (GO:0097435),0.069868021,0.221907299,7.110184695,COL1A1;COL1A2;LUM;FBLN5
Negative Regulation Of Epithelial Cell Differentiation (GO:0030857),0.07105545,0.221907299,38.72587138,DLL1
Astrocyte Development (GO:0014002),0.07105545,0.221907299,38.72587138,DLL1
Cellular Response To Zinc Ion (GO:0071294),0.07105545,0.221907299,38.72587138,GLRA2
Positive Regulation Of Endothelial Cell Apoptotic Process (GO:2000353),0.07105545,0.221907299,38.72587138,ITGA4
Stem Cell Development (GO:0048864),0.07105545,0.221907299,38.72587138,KBTBD8
Folic Acid-Containing Compound Metabolic Process (GO:0006760),0.07105545,0.221907299,38.72587138,MTHFD2
Positive Regulation Of Sprouting Angiogenesis (GO:1903672),0.07105545,0.221907299,38.72587138,DLL1
Positive Regulation Of Syncytium Formation By Plasma Membrane Fusion (GO:0060143),0.07105545,0.221907299,38.72587138,RAPGEF3
Positive Regulation Of Transmembrane Transport (GO:0034764),0.07105545,0.221907299,38.72587138,SLC38A1
Lymphocyte Differentiation (GO:0030098),0.073510785,0.224549471,12.10635127,VCAM1;ITGA4
Regulation Of Actin Cytoskeleton Organization (GO:0032956),0.073510785,0.224549471,12.10635127,BST1;RAPGEF3
B Cell Activation (GO:0042113),0.074911963,0.224549471,11.88463952,VCAM1;ITGA4
Negative Regulation Of Interleukin-10 Production (GO:0032693),0.075610686,0.224549471,35.29303732,DLL1
DNA-templated Transcription Termination (GO:0006353),0.075610686,0.224549471,35.29303732,POLR3K
Regulation Of Fibrinolysis (GO:0051917),0.075610686,0.224549471,35.29303732,SERPINE1
Regulation Of Nucleocytoplasmic Transport (GO:0046822),0.075610686,0.224549471,35.29303732,FRAT1
Regulation Of Osteoblast Proliferation (GO:0033688),0.075610686,0.224549471,35.29303732,TMEM119
Regulation Of Plasminogen Activation (GO:0010755),0.075610686,0.224549471,35.29303732,SERPINE1
Oligodendrocyte Development (GO:0014003),0.075610686,0.224549471,35.29303732,HES5
Regulation Of Response To Cytokine Stimulus (GO:0060759),0.075610686,0.224549471,35.29303732,CD24
"Regulation Of Synaptic Transmission, GABAergic (GO:0032228)",0.075610686,0.224549471,35.29303732,SLC38A1
Cellular Response To Nitrogen Compound (GO:1901699),0.075610686,0.224549471,35.29303732,BLM
Regulation Of Endothelial Cell Proliferation (GO:0001936),0.076321707,0.22580896,11.66888711,TNMD;THBS4
Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),0.079166434,0.225842144,11.25440027,ZEB2;HES5
DNA Biosynthetic Process (GO:0071897),0.080143812,0.225842144,32.33951285,POLD1
Negative Regulation Of Striated Muscle Cell Differentiation (GO:0051154),0.080143812,0.225842144,32.33951285,TMEM119
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),0.080143812,0.225842144,32.33951285,USP44
Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090266),0.080143812,0.225842144,32.33951285,USP44
Neural Tube Development (GO:0021915),0.080143812,0.225842144,32.33951285,HES5
Nicotinamide Nucleotide Metabolic Process (GO:0046496),0.080143812,0.225842144,32.33951285,NOCT
Peptidyl-Threonine Dephosphorylation (GO:0035970),0.080143812,0.225842144,32.33951285,DUSP10
Regulation Of Tubulin Deacetylation (GO:0090043),0.080143812,0.225842144,32.33951285,SGF29
Regulation Of Ubiquitin Protein Ligase Activity (GO:1904666),0.080143812,0.225842144,32.33951285,USP44
Embryonic Axis Specification (GO:0000578),0.080143812,0.225842144,32.33951285,CXXC4
Extracellular Matrix Assembly (GO:0085029),0.080143812,0.225842144,32.33951285,FBLN5
Positive Regulation Of Regulatory T Cell Differentiation (GO:0045591),0.080143812,0.225842144,32.33951285,DUSP10
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.081534241,0.225842144,7.643593065,COL1A1;FRAT1;ZEB2
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),0.083494916,0.225842144,10.67224276,AKR1B1;PASK
3'-UTR-mediated mRNA Stabilization (GO:0070935),0.084654933,0.225842144,29.77530815,HNRNPA0
Regulation Of Epidermal Cell Differentiation (GO:0045604),0.084654933,0.225842144,29.77530815,DLL1
Regulation Of Histone Modification (GO:0031056),0.084654933,0.225842144,29.77530815,SGF29
Neural Crest Cell Differentiation (GO:0014033),0.084654933,0.225842144,29.77530815,KBTBD8
Neuron Fate Commitment (GO:0048663),0.084654933,0.225842144,29.77530815,DLL1
Regulation Of Nervous System Process (GO:0031644),0.084654933,0.225842144,29.77530815,NPTXR
Regulation Of Oligodendrocyte Differentiation (GO:0048713),0.084654933,0.225842144,29.77530815,HES5
Regulation Of Protein Deacetylation (GO:0090311),0.084654933,0.225842144,29.77530815,SGF29
Cellular Response To Inorganic Substance (GO:0071241),0.084654933,0.225842144,29.77530815,BLM
Endothelial Cell Proliferation (GO:0001935),0.084654933,0.225842144,29.77530815,PRKX
Positive Regulation Of Glycolytic Process (GO:0045821),0.084654933,0.225842144,29.77530815,SLC4A4
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),0.084654933,0.225842144,29.77530815,SERPINE1
Positive Regulation Of Neuroblast Proliferation (GO:0002052),0.084654933,0.225842144,29.77530815,BCAN
Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),0.084654933,0.225842144,29.77530815,THBS4
Positive Regulation Of Gene Expression (GO:0010628),0.087011554,0.228373438,5.36900792,TMEM119;AKR1B1;SGF29;PASK;DLL1
Hemopoiesis (GO:0030097),0.087894384,0.228373438,10.13328248,PRKX;DLL1
Visual Perception (GO:0007601),0.087894384,0.228373438,10.13328248,COL1A1;LUM
NADP Metabolic Process (GO:0006739),0.089144156,0.228373438,27.53125985,NOCT
Regulation Of Granulocyte Chemotaxis (GO:0071622),0.089144156,0.228373438,27.53125985,BST1
Bicarbonate Transport (GO:0015701),0.089144156,0.228373438,27.53125985,SLC4A4
Oligodendrocyte Differentiation (GO:0048709),0.089144156,0.228373438,27.53125985,HES5
Regulation Of Smooth Muscle Cell Migration (GO:0014910),0.089144156,0.228373438,27.53125985,SERPINE1
Regulation Of Tissue Remodeling (GO:0034103),0.089144156,0.228373438,27.53125985,THBS4
Regulation Of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900746),0.089144156,0.228373438,27.53125985,DLL1
Receptor Clustering (GO:0043113),0.089144156,0.228373438,27.53125985,ITGA4
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),0.089181626,0.228373438,4.382972184,ZEB2;PSMC3;LMO3;IGF2;TAF4B;AKR1B1;OLIG1;DLL1
Sensory Perception Of Light Stimulus (GO:0050953),0.089376136,0.228373438,9.962475191,COL1A1;LUM
Positive Regulation Of Vasculature Development (GO:1904018),0.092361886,0.23230278,9.633253533,SERPINE1;RAPGEF3
DNA Unwinding Involved In DNA Replication (GO:0006268),0.093611586,0.23230278,25.55338909,MCM5
Ameboidal-Type Cell Migration (GO:0001667),0.093611586,0.23230278,25.55338909,ITGA4
Calcium-Mediated Signaling Using Intracellular Calcium Source (GO:0035584),0.093611586,0.23230278,25.55338909,VCAM1
Regulation Of Protein Localization To Cell Periphery (GO:1904375),0.093611586,0.23230278,25.55338909,AKR1B1
Endothelial Cell Development (GO:0001885),0.093611586,0.23230278,25.55338909,RAPGEF3
Glutamate Metabolic Process (GO:0006536),0.093611586,0.23230278,25.55338909,GOT2
Cellular Response To Organonitrogen Compound (GO:0071417),0.093865672,0.23230278,9.474568524,GLRA2;RAPGEF3
Intrinsic Apoptotic Signaling Pathway (GO:0097193),0.093865672,0.23230278,9.474568524,CHAC1;CD24
Negative Regulation Of MAPK Cascade (GO:0043409),0.093865672,0.23230278,9.474568524,DUSP10;LMO3
DNA Replication Initiation (GO:0006270),0.098057327,0.23744959,23.7989897,MCM5
Regulation Of Histone Deacetylation (GO:0031063),0.098057327,0.23744959,23.7989897,SGF29
Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),0.098057327,0.23744959,23.7989897,CDC7
Positive Regulation Of Blood Coagulation (GO:0030194),0.098057327,0.23744959,23.7989897,SERPINE1
Skin Epidermis Development (GO:0098773),0.098057327,0.23744959,23.7989897,DLL1
Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),0.098057327,0.23744959,23.7989897,THBS4
Negative Regulation Of Biomineral Tissue Development (GO:0070168),0.098057327,0.23744959,23.7989897,ASPN
Positive Regulation Of Protein Modification Process (GO:0031401),0.098607266,0.238048828,6.485190803,IGF2;TMEM119;MOB3B
Negative Regulation Of Developmental Process (GO:0051093),0.099951113,0.240555124,8.876431376,DLL1;RAPGEF3
Response To Lipid (GO:0033993),0.101489532,0.242772832,8.735475631,NOCT;HNRNPA0
Regulation Of JNK Cascade (GO:0046328),0.101489532,0.242772832,8.735475631,DUSP10;CCN2
Regulation Of Regulatory T Cell Differentiation (GO:0045589),0.102481484,0.242779066,22.23385962,DUSP10
Placenta Development (GO:0001890),0.102481484,0.242779066,22.23385962,IGF2
Vesicle Transport Along Microtubule (GO:0047496),0.102481484,0.242779066,22.23385962,BICDL1
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.103034572,0.242779066,8.597738337,ZEB2;ASPN
Mitotic Cell Cycle Phase Transition (GO:0044772),0.103034572,0.242779066,8.597738337,EIF4EBP1;CDC7
Protein Deubiquitination (GO:0016579),0.104586132,0.245699362,8.463120355,STAMBPL1;USP44
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),0.106884161,0.246414317,20.83030537,SERPINE1
Regulation Of Myotube Differentiation (GO:0010830),0.106884161,0.246414317,20.83030537,TMEM119
Cell-Cell Signaling By Wnt (GO:0198738),0.106884161,0.246414317,20.83030537,CD24
Positive Regulation Of Epithelial Cell Apoptotic Process (GO:1904037),0.106884161,0.246414317,20.83030537,ITGA4
Translesion Synthesis (GO:0019985),0.106884161,0.246414317,20.83030537,POLD1
Positive Regulation Of Neutrophil Migration (GO:1902624),0.106884161,0.246414317,20.83030537,THBS4
Regulation Of Cytoskeleton Organization (GO:0051493),0.107708418,0.246414317,8.202864945,BST1;RAPGEF3
Response To Endoplasmic Reticulum Stress (GO:0034976),0.107708418,0.246414317,8.202864945,CHAC1;THBS4
Protein Modification By Small Protein Removal (GO:0070646),0.107708418,0.246414317,8.202864945,STAMBPL1;USP44
Neuromuscular Junction Development (GO:0007528),0.11126546,0.248766809,19.5656799,ZC4H2
Regulation Of Muscle Cell Differentiation (GO:0051147),0.11126546,0.248766809,19.5656799,IGF2
Regulation Of Neuroblast Proliferation (GO:1902692),0.11126546,0.248766809,19.5656799,BCAN
Positive Regulation Of BMP Signaling Pathway (GO:0030513),0.11126546,0.248766809,19.5656799,HES5
Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),0.11126546,0.248766809,19.5656799,CDC7
Positive Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903846),0.11126546,0.248766809,19.5656799,ZEB2
Gliogenesis (GO:0042063),0.11126546,0.248766809,19.5656799,BCAN
Positive Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030511),0.11126546,0.248766809,19.5656799,ZEB2
Positive Regulation Of Cell Cycle Process (GO:0090068),0.114026918,0.249565016,7.715831906,IGF2;CDC7
Positive Regulation Of Protein Phosphorylation (GO:0001934),0.114121113,0.249565016,4.835730641,IGF2;TMEM119;MOB3B;THBS4
Regulation Of Hippo Signaling (GO:0035330),0.115625484,0.249565016,18.42129522,MOB3B
Negative Regulation Of Response To Wounding (GO:1903035),0.115625484,0.249565016,18.42129522,SERPINE1
Regulation Of Monocyte Chemotaxis (GO:0090025),0.115625484,0.249565016,18.42129522,SERPINE1
Regulation Of Myelination (GO:0031641),0.115625484,0.249565016,18.42129522,HES5
Regulation Of Neutrophil Chemotaxis (GO:0090022),0.115625484,0.249565016,18.42129522,THBS4
Regulation Of Protein Processing (GO:0070613),0.115625484,0.249565016,18.42129522,CHAC1
Cellular Response To Steroid Hormone Stimulus (GO:0071383),0.115625484,0.249565016,18.42129522,AKR1B1
Response To Zinc Ion (GO:0010043),0.115625484,0.249565016,18.42129522,GLRA2
Mismatch Repair (GO:0006298),0.115625484,0.249565016,18.42129522,RNASEH2A
Regulation Of Actin Cytoskeleton Reorganization (GO:2000249),0.115625484,0.249565016,18.42129522,RAPGEF3
Negative Regulation Of Cell Population Proliferation (GO:0008285),0.115744893,0.249565016,4.778141579,TES;DUSP10;AKR1B1;DLL1
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),0.118051238,0.252739085,5.504487116,DUSP10;LMO3;CCN2
Negative Regulation Of Endothelial Cell Apoptotic Process (GO:2000352),0.119964336,0.252739085,17.38160274,SERPINE1
L-amino Acid Transport (GO:0015807),0.119964336,0.252739085,17.38160274,SLC38A1
cAMP-mediated Signaling (GO:0019933),0.119964336,0.252739085,17.38160274,RAPGEF3
Camera-Type Eye Development (GO:0043010),0.119964336,0.252739085,17.38160274,HES5
Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),0.119964336,0.252739085,17.38160274,CDHR3
Positive Regulation Of Nuclear Division (GO:0051785),0.119964336,0.252739085,17.38160274,IGF2
Protein Localization To Cell Surface (GO:0034394),0.119964336,0.252739085,17.38160274,FBLN5
Modulation Of Chemical Synaptic Transmission (GO:0050804),0.122055806,0.252739085,7.163381655,SLC38A1;NPTXR
Negative Regulation Of Cellular Process (GO:0048523),0.123847816,0.252739085,4.088664504,BLM;TES;AKR1B1;CCN2;DLL1
DNA Synthesis Involved In DNA Repair (GO:0000731),0.124282117,0.252739085,16.43356791,POLD1
Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),0.124282117,0.252739085,16.43356791,CD24
Cellular Response To Acid Chemical (GO:0071229),0.124282117,0.252739085,16.43356791,GLRA2
Regulation Of Transcription Regulatory Region DNA Binding (GO:2000677),0.124282117,0.252739085,16.43356791,ZC4H2
Positive Regulation Of TORC1 Signaling (GO:1904263),0.124282117,0.252739085,16.43356791,STAMBPL1
Clathrin-Dependent Endocytosis (GO:0072583),0.124282117,0.252739085,16.43356791,DLL1
"Synaptic Transmission, Glutamatergic (GO:0035249)",0.124282117,0.252739085,16.43356791,CDHR3
Positive Regulation Of Mitotic Cell Cycle (GO:0045931),0.124282117,0.252739085,16.43356791,EIF4EBP1
In Utero Embryonic Development (GO:0001701),0.124282117,0.252739085,16.43356791,IGF2
Monoubiquitinated Histone H2A Deubiquitination (GO:0035522),0.124282117,0.252739085,16.43356791,SGF29
Monoubiquitinated Histone Deubiquitination (GO:0035521),0.124282117,0.252739085,16.43356791,SGF29
Negative Regulation Of Notch Signaling Pathway (GO:0045746),0.124282117,0.252739085,16.43356791,CHAC1
Protein-Containing Complex Organization (GO:0043933),0.126938437,0.254890723,6.858676302,MAGI1;HES5
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),0.128576324,0.254890723,6.761204497,DLL1;RAPGEF3
Negative Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045841),0.128578929,0.254890723,15.56618752,USP44
Negative Regulation Of Wound Healing (GO:0061045),0.128578929,0.254890723,15.56618752,SERPINE1
Regulation Of Protein Localization To Membrane (GO:1905475),0.128578929,0.254890723,15.56618752,AKR1B1
Determination Of Bilateral Symmetry (GO:0009855),0.128578929,0.254890723,15.56618752,DLL1
Diterpenoid Metabolic Process (GO:0016101),0.128578929,0.254890723,15.56618752,AKR1B1
Establishment Of Endothelial Barrier (GO:0061028),0.128578929,0.254890723,15.56618752,RAPGEF3
Transcription By RNA Polymerase III (GO:0006383),0.128578929,0.254890723,15.56618752,POLR3K
Regulation Of Bone Resorption (GO:0045124),0.128578929,0.254890723,15.56618752,TMEM119
Regulation Of Developmental Growth (GO:0048638),0.132854872,0.256266628,14.7701134,DLL1
TOR Signaling (GO:0031929),0.132854872,0.256266628,14.7701134,EIF4EBP1
Alpha-Amino Acid Catabolic Process (GO:1901606),0.132854872,0.256266628,14.7701134,GOT2
Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.132854872,0.256266628,14.7701134,DUSP10
Positive Regulation Of B Cell Proliferation (GO:0030890),0.132854872,0.256266628,14.7701134,BST1
Chondrocyte Differentiation (GO:0002062),0.132854872,0.256266628,14.7701134,HES5
Response To Alcohol (GO:0097305),0.132854872,0.256266628,14.7701134,GOT2
Response To Steroid Hormone (GO:0048545),0.132854872,0.256266628,14.7701134,AKR1B1
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),0.132854872,0.256266628,14.7701134,BCAN
Morphogenesis Of An Epithelium (GO:0002009),0.132854872,0.256266628,14.7701134,PRKX
Regulation Of Blood Coagulation (GO:0030193),0.132854872,0.256266628,14.7701134,SERPINE1
DNA Geometric Change (GO:0032392),0.137110046,0.260641562,14.03735619,BLM
Regulation Of Vasculature Development (GO:1901342),0.137110046,0.260641562,14.03735619,RAPGEF3
Response To Amino Acid (GO:0043200),0.137110046,0.260641562,14.03735619,GLRA2
Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),0.137110046,0.260641562,14.03735619,CHAC1
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),0.137110046,0.260641562,14.03735619,BLM
Negative Regulation Of Blood Coagulation (GO:0030195),0.137110046,0.260641562,14.03735619,SERPINE1
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.138267622,0.261122448,3.728885857,COL1A1;BLM;AKR1B1;SGF29;HES5
Negative Regulation Of Cell Motility (GO:2000146),0.138506125,0.261122448,6.215667623,DUSP10;SERPINE1
Negative Regulation Of Developmental Growth (GO:0048640),0.141344553,0.261122448,13.36105006,DUSP10
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),0.141344553,0.261122448,13.36105006,SERPINE1
acyl-CoA Metabolic Process (GO:0006637),0.141344553,0.261122448,13.36105006,DLST
Cellular Response To cAMP (GO:0071320),0.141344553,0.261122448,13.36105006,RAPGEF3
Central Nervous System Neuron Differentiation (GO:0021953),0.141344553,0.261122448,13.36105006,ZC4H2
Endodermal Cell Differentiation (GO:0035987),0.141344553,0.261122448,13.36105006,ITGA4
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),0.141344553,0.261122448,13.36105006,SERPINE1
Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),0.141344553,0.261122448,13.36105006,PSMC3
Protein Localization To Chromatin (GO:0071168),0.141344553,0.261122448,13.36105006,SGF29
Negative Regulation Of Cell-Matrix Adhesion (GO:0001953),0.141344553,0.261122448,13.36105006,SERPINE1
Positive Regulation Of Signal Transduction (GO:0009967),0.14218299,0.262056237,4.599795069,LMO3;IGF2;DLL1
Negative Regulation Of Osteoblast Differentiation (GO:0045668),0.14555849,0.267026879,12.73526431,NOCT
Left/Right Pattern Formation (GO:0060972),0.14555849,0.267026879,12.73526431,DLL1
Negative Regulation Of Epithelial Cell Migration (GO:0010633),0.149751956,0.269690594,12.15485142,DUSP10
Regulation Of Sprouting Angiogenesis (GO:1903670),0.149751956,0.269690594,12.15485142,DLL1
Positive Regulation Of Notch Signaling Pathway (GO:0045747),0.149751956,0.269690594,12.15485142,DLL1
Epithelial Tube Morphogenesis (GO:0060562),0.149751956,0.269690594,12.15485142,PRKX
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),0.149751956,0.269690594,12.15485142,SLC4A4
Protein K63-linked Deubiquitination (GO:0070536),0.149751956,0.269690594,12.15485142,STAMBPL1
Monoubiquitinated Protein Deubiquitination (GO:0035520),0.149751956,0.269690594,12.15485142,SGF29
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),0.149751956,0.269690594,12.15485142,SERPINE1
Response To Estrogen (GO:0043627),0.153925051,0.272222506,11.61532352,CD24
Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),0.153925051,0.272222506,11.61532352,SLC4A4
Embryonic Skeletal System Development (GO:0048706),0.153925051,0.272222506,11.61532352,COL1A1
Smoothened Signaling Pathway (GO:0007224),0.153925051,0.272222506,11.61532352,HES5
Transcription Initiation-Coupled Chromatin Remodeling (GO:0045815),0.153925051,0.272222506,11.61532352,SGF29
Histone Deubiquitination (GO:0016578),0.153925051,0.272222506,11.61532352,SGF29
Purine Nucleotide Metabolic Process (GO:0006163),0.153925051,0.272222506,11.61532352,NOCT
Negative Regulation Of JNK Cascade (GO:0046329),0.153925051,0.272222506,11.61532352,DUSP10
Positive Regulation Of Transferase Activity (GO:0051347),0.155408208,0.274024858,5.435734948,RFC5;IGF2
Ras Protein Signal Transduction (GO:0007265),0.157120129,0.274024858,5.365421592,COL1A2;RAPGEF3
Regulation Of Cell Adhesion (GO:0030155),0.157120129,0.274024858,5.365421592,PRKX;DLL1
Adherens Junction Organization (GO:0034332),0.158077872,0.274024858,11.11275137,CDHR3
Neutral Amino Acid Transport (GO:0015804),0.158077872,0.274024858,11.11275137,SLC38A1
One-Carbon Compound Transport (GO:0019755),0.158077872,0.274024858,11.11275137,SLC4A4
Endoderm Formation (GO:0001706),0.158077872,0.274024858,11.11275137,ITGA4
Positive Regulation Of Mitotic Nuclear Division (GO:0045840),0.158077872,0.274024858,11.11275137,IGF2
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),0.158077872,0.274024858,11.11275137,CDC7
Central Nervous System Development (GO:0007417),0.161865537,0.278125657,4.029863033,DCX;DLL1;HES5
Regulation Of Intracellular Protein Transport (GO:0033157),0.162210517,0.278125657,10.64368118,FRAT1
Base-Excision Repair (GO:0006284),0.162210517,0.278125657,10.64368118,POLD1
Substrate Adhesion-Dependent Cell Spreading (GO:0034446),0.162210517,0.278125657,10.64368118,ITGA4
Histone H3 Acetylation (GO:0043966),0.162210517,0.278125657,10.64368118,SGF29
Protein Ubiquitination (GO:0016567),0.164140621,0.280214032,3.48209032,ZC4H2;UBE2QL1;KLHL13;KBTBD8
Regulation Of Cell Migration (GO:0030334),0.164140621,0.280214032,3.48209032,COL1A1;DUSP10;SERPINE1;PRKX
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),0.166323082,0.280291789,10.20506582,TNMD
RNA Stabilization (GO:0043489),0.166323082,0.280291789,10.20506582,NOCT
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),0.166323082,0.280291789,10.20506582,DUSP10
Regulation Of p38MAPK Cascade (GO:1900744),0.166323082,0.280291789,10.20506582,DUSP10
Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),0.166323082,0.280291789,10.20506582,HES5
Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),0.166323082,0.280291789,10.20506582,HES5
Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),0.170415664,0.281167982,9.794207408,SERPINE1
Amino Acid Catabolic Process (GO:0009063),0.170415664,0.281167982,9.794207408,GOT2
Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),0.170415664,0.281167982,9.794207408,CDHR3
Response To cAMP (GO:0051591),0.170415664,0.281167982,9.794207408,RAPGEF3
Connective Tissue Development (GO:0061448),0.170415664,0.281167982,9.794207408,HES5
Positive Regulation Of Bone Mineralization (GO:0030501),0.170415664,0.281167982,9.794207408,TMEM119
Fatty Acid Transport (GO:0015908),0.170415664,0.281167982,9.794207408,GOT2
Heart Looping (GO:0001947),0.170415664,0.281167982,9.794207408,DLL1
Import Into Cell (GO:0098657),0.170415664,0.281167982,9.794207408,SLC38A1
mRNA Transcription By RNA Polymerase II (GO:0042789),0.170415664,0.281167982,9.794207408,TAF4B
Epithelium Development (GO:0060429),0.174427093,0.284901118,4.727029404,DLL1;HES5
Organelle Transport Along Microtubule (GO:0072384),0.174488359,0.284901118,9.40870942,BICDL1
Carboxylic Acid Transmembrane Transport (GO:1905039),0.174488359,0.284901118,9.40870942,SLC38A1
Regulation Of Receptor-Mediated Endocytosis (GO:0048259),0.174488359,0.284901118,9.40870942,SERPINE1
Vesicle Cytoskeletal Trafficking (GO:0099518),0.174488359,0.284901118,9.40870942,BICDL1
Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),0.178541264,0.285593444,9.046436299,CD24
L-alpha-amino Acid Transmembrane Transport (GO:1902475),0.178541264,0.285593444,9.046436299,SLC38A1
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),0.178541264,0.285593444,9.046436299,USP44
Regulation Of Glycolytic Process (GO:0006110),0.178541264,0.285593444,9.046436299,SLC4A4
Cyclic-Nucleotide-Mediated Signaling (GO:0019935),0.178541264,0.285593444,9.046436299,RAPGEF3
Positive Regulation Of Catalytic Activity (GO:0043085),0.178541264,0.285593444,9.046436299,IGF2
Retinoid Metabolic Process (GO:0001523),0.178541264,0.285593444,9.046436299,AKR1B1
Endothelial Cell Migration (GO:0043542),0.178541264,0.285593444,9.046436299,PRKX
Water-Soluble Vitamin Metabolic Process (GO:0006767),0.178541264,0.285593444,9.046436299,MTHFD2
Positive Regulation Of Wound Healing (GO:0090303),0.178541264,0.285593444,9.046436299,SERPINE1
Peptidyl-Serine Phosphorylation (GO:0018105),0.18143534,0.28910686,4.501011939,CDC7;PRKX
Negative Regulation Of mRNA Catabolic Process (GO:1902373),0.182574472,0.28910686,8.705479391,NOCT
Negative Regulation Of Proteolysis (GO:0045861),0.182574472,0.28910686,8.705479391,CHAC1
Positive Regulation Of Ossification (GO:0045778),0.182574472,0.28910686,8.705479391,TMEM119
Negative Regulation Of DNA Recombination (GO:0045910),0.182574472,0.28910686,8.705479391,BLM
DNA Recombination (GO:0006310),0.186588079,0.291938009,8.38412801,BLM
Amino Acid Transmembrane Transport (GO:0003333),0.186588079,0.291938009,8.38412801,SLC38A1
Regulation Of Neurotransmitter Receptor Activity (GO:0099601),0.186588079,0.291938009,8.38412801,NPTXR
Determination Of Heart Left/Right Asymmetry (GO:0061371),0.186588079,0.291938009,8.38412801,DLL1
Embryonic Heart Tube Morphogenesis (GO:0003143),0.186588079,0.291938009,8.38412801,DLL1
Positive Regulation Of Neuron Differentiation (GO:0045666),0.186588079,0.291938009,8.38412801,ZC4H2
Protein Autophosphorylation (GO:0046777),0.188485759,0.294094462,4.289599398,PRKX;PASK
Negative Regulation Of Cell Migration (GO:0030336),0.190254454,0.294094462,4.238881301,DUSP10;SERPINE1
Positive Regulation Of Biomineral Tissue Development (GO:0070169),0.19058218,0.294094462,8.080844797,TMEM119
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),0.19058218,0.294094462,8.080844797,SERPINE1
mRNA Transcription (GO:0009299),0.19058218,0.294094462,8.080844797,TAF4B
Regulation Of JUN Kinase Activity (GO:0043506),0.19058218,0.294094462,8.080844797,DUSP10
Regulation Of Cell-Cell Adhesion (GO:0022407),0.19058218,0.294094462,8.080844797,MAGI1
Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),0.194556867,0.294621474,7.794244625,IGF2
Neural Crest Cell Development (GO:0014032),0.194556867,0.294621474,7.794244625,KBTBD8
Nucleobase-Containing Compound Catabolic Process (GO:0034655),0.194556867,0.294621474,7.794244625,RNASEH2A
Cellular Response To Ketone (GO:1901655),0.194556867,0.294621474,7.794244625,AKR1B1
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),0.194556867,0.294621474,7.794244625,RAPGEF3
Positive Regulation Of Osteoblast Differentiation (GO:0045669),0.194556867,0.294621474,7.794244625,TMEM119
Regulation Of B Cell Proliferation (GO:0030888),0.194556867,0.294621474,7.794244625,BST1
Regulation Of DNA Recombination (GO:0000018),0.194556867,0.294621474,7.794244625,BLM
Regulation Of Cell-Substrate Adhesion (GO:0010810),0.194556867,0.294621474,7.794244625,BST1
Positive Regulation Of MAPK Cascade (GO:0043410),0.194667302,0.294621474,3.29845693,IGF2;CCN2;CD24
Peptidyl-Serine Modification (GO:0018209),0.195574114,0.295425773,4.09156271,CDC7;PRKX
Regulation Of Stem Cell Differentiation (GO:2000736),0.198512234,0.298717263,7.523076495,HES5
Determination Of Left/Right Symmetry (GO:0007368),0.198512234,0.298717263,7.523076495,DLL1
T Cell Differentiation (GO:0030217),0.202448375,0.2994866,7.266207924,USP44
Regulation Of Interleukin-10 Production (GO:0032653),0.202448375,0.2994866,7.266207924,DLL1
Amino Acid Transport (GO:0006865),0.202448375,0.2994866,7.266207924,SLC38A1
Antiviral Innate Immune Response (GO:0140374),0.202448375,0.2994866,7.266207924,USP44
Replication Fork Processing (GO:0031297),0.202448375,0.2994866,7.266207924,BLM
Positive Regulation Of Cell-Cell Adhesion (GO:0022409),0.202448375,0.2994866,7.266207924,MAGI1
Development Of Primary Male Sexual Characteristics (GO:0046546),0.202448375,0.2994866,7.266207924,AKR1B1
Male Gonad Development (GO:0008584),0.202448375,0.2994866,7.266207924,AKR1B1
Mitotic G2/M Transition Checkpoint (GO:0044818),0.202448375,0.2994866,7.266207924,BLM
Regulation Of Wound Healing (GO:0061041),0.206365382,0.301876497,7.022611448,SERPINE1
Positive Regulation Of TOR Signaling (GO:0032008),0.206365382,0.301876497,7.022611448,STAMBPL1
Response To Organonitrogen Compound (GO:0010243),0.206365382,0.301876497,7.022611448,GLRA2
Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),0.206365382,0.301876497,7.022611448,COL1A1
Insulin Receptor Signaling Pathway (GO:0008286),0.206365382,0.301876497,7.022611448,IGF2
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),0.206365382,0.301876497,7.022611448,HES5
Cellular Response To Radiation (GO:0071478),0.210263346,0.305308585,6.79135291,BLM
Chloride Transmembrane Transport (GO:1902476),0.210263346,0.305308585,6.79135291,GLRA2
Regulation Of DNA Binding (GO:0051101),0.210263346,0.305308585,6.79135291,ZC4H2
Myelination (GO:0042552),0.210263346,0.305308585,6.79135291,HES5
Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),0.21414236,0.308663071,6.57158127,USP44
Neurogenesis (GO:0022008),0.21414236,0.308663071,6.57158127,CHAC1
Fatty Acid Beta-Oxidation (GO:0006635),0.21414236,0.308663071,6.57158127,ECI1
Negative Regulation Of DNA Metabolic Process (GO:0051053),0.21414236,0.308663071,6.57158127,BLM
Protein-Containing Complex Assembly (GO:0065003),0.217389046,0.311375641,2.902912483,MAGI1;BLM;HES5
Regulation Of Epithelial Cell Migration (GO:0010632),0.218002514,0.311375641,6.362519703,DUSP10
Positive Regulation Of Developmental Growth (GO:0048639),0.218002514,0.311375641,6.362519703,DLL1
Positive Regulation Of Transport (GO:0051050),0.218002514,0.311375641,6.362519703,DLL1
Regulation Of TORC1 Signaling (GO:1903432),0.218002514,0.311375641,6.362519703,STAMBPL1
Negative Regulation Of MAP Kinase Activity (GO:0043407),0.221843899,0.316288313,6.16345781,DUSP10
Rho Protein Signal Transduction (GO:0007266),0.225666607,0.316576862,5.97374478,COL1A2
Neurotransmitter Transport (GO:0006836),0.225666607,0.316576862,5.97374478,SLC38A1
Regulation Of Peptide Hormone Secretion (GO:0090276),0.225666607,0.316576862,5.97374478,PASK
Cartilage Development (GO:0051216),0.225666607,0.316576862,5.97374478,HES5
Cellular Response To Ionizing Radiation (GO:0071479),0.225666607,0.316576862,5.97374478,BLM
Positive Regulation Of B Cell Activation (GO:0050871),0.225666607,0.316576862,5.97374478,BST1
Sprouting Angiogenesis (GO:0002040),0.225666607,0.316576862,5.97374478,DLL1
Fatty Acid Oxidation (GO:0019395),0.225666607,0.316576862,5.97374478,ECI1
Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),0.225666607,0.316576862,5.97374478,TAF4B
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),0.229470725,0.318506986,5.792783374,BLM
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),0.229470725,0.318506986,5.792783374,PSMC3
Carboxylic Acid Transport (GO:0046942),0.229470725,0.318506986,5.792783374,SLC38A1
Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),0.229470725,0.318506986,5.792783374,HES5
Gonad Development (GO:0008406),0.229470725,0.318506986,5.792783374,AKR1B1
"Regulation Of Alternative mRNA Splicing, Via Spliceosome (GO:0000381)",0.229470725,0.318506986,5.792783374,HNRNPA0
Protein Phosphorylation (GO:0006468),0.229992981,0.318669852,2.446904954,TAF4B;CDC7;PRKX;PASK
Regulation Of Myoblast Differentiation (GO:0045661),0.233256345,0.32093137,5.620024608,DLL1
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),0.233256345,0.32093137,5.620024608,HES5
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),0.233256345,0.32093137,5.620024608,SERPINE1
Monoatomic Anion Transmembrane Transport (GO:0098656),0.233256345,0.32093137,5.620024608,GLRA2
Defense Response To Virus (GO:0051607),0.236871596,0.324413109,3.163354937,USP44;AKAP1
Neuron Migration (GO:0001764),0.237023555,0.324413109,5.454963063,DCX
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),0.237023555,0.324413109,5.454963063,HES5
RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),0.240772444,0.327267553,5.29713271,TAF4B
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),0.240772444,0.327267553,5.29713271,BST1
Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),0.240772444,0.327267553,5.29713271,TAF4B
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),0.240772444,0.327267553,5.29713271,BLM
Neuron Projection Development (GO:0031175),0.242303808,0.328215314,3.063925498,BICDL1;OLIG1
Transcription By RNA Polymerase II (GO:0006366),0.242303808,0.328215314,3.063925498,NOCT;TAF4B
RNA Catabolic Process (GO:0006401),0.244503099,0.329493046,5.14610322,RNASEH2A
Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),0.244503099,0.329493046,5.14610322,TAF4B
Myeloid Cell Differentiation (GO:0030099),0.244503099,0.329493046,5.14610322,PRKX
Eye Development (GO:0001654),0.248215609,0.33335441,5.001476661,HES5
Regulation Of Bone Mineralization (GO:0030500),0.248215609,0.33335441,5.001476661,TMEM119
DNA-templated Transcription Initiation (GO:0006352),0.251910061,0.336022404,4.86288456,TAF4B
Anterior/Posterior Pattern Specification (GO:0009952),0.251910061,0.336022404,4.86288456,HES5
Transcription Preinitiation Complex Assembly (GO:0070897),0.251910061,0.336022404,4.86288456,TAF4B
Regulation Of Cell Death (GO:0010941),0.251910061,0.336022404,4.86288456,CCN2
DNA-templated Transcription (GO:0006351),0.254999763,0.336928993,2.847582266,NOCT;POLR3K
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),0.255586542,0.336928993,4.729985272,AKR1B1
Negative Regulation Of Peptidase Activity (GO:0010466),0.255586542,0.336928993,4.729985272,SERPINE1
Response To Light Stimulus (GO:0009416),0.255586542,0.336928993,4.729985272,POLD1
Histone Acetylation (GO:0016573),0.255586542,0.336928993,4.729985272,SGF29
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),0.255586542,0.336928993,4.729985272,HMCN1
protein-DNA Complex Organization (GO:0071824),0.255586542,0.336928993,4.729985272,SATB1
Positive Regulation Of Interleukin-8 Production (GO:0032757),0.259245138,0.340610891,4.602461627,SERPINE1
Fatty Acid Catabolic Process (GO:0009062),0.259245138,0.340610891,4.602461627,ECI1
Regulation Of Embryonic Development (GO:0045995),0.262885936,0.344244978,4.48001881,SGF29
Protein-Containing Complex Disassembly (GO:0032984),0.262885936,0.344244978,4.48001881,FRAT1
Regulation Of MAPK Cascade (GO:0043408),0.264078954,0.344938996,2.70531053,IGF2;CD24
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),0.264292522,0.344938996,2.274662573,TMEM119;AKR1B1;DLL1
Telomere Organization (GO:0032200),0.266509021,0.346109901,4.362382466,BLM
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),0.266509021,0.346109901,4.362382466,CDC7
Inorganic Anion Transmembrane Transport (GO:0098661),0.266509021,0.346109901,4.362382466,GLRA2
Positive Regulation Of T Cell Differentiation (GO:0045582),0.270114479,0.349638314,4.249296983,DUSP10
Negative Regulation Of Cell Death (GO:0060548),0.270114479,0.349638314,4.249296983,CCN2
Canonical Wnt Signaling Pathway (GO:0060070),0.273702394,0.350250055,4.140523949,FRAT1
Cellular Response To Light Stimulus (GO:0071482),0.273702394,0.350250055,4.140523949,POLD1
Regulation Of Translational Initiation (GO:0006446),0.273702394,0.350250055,4.140523949,EIF4EBP1
Positive Regulation Of DNA Biosynthetic Process (GO:2000573),0.273702394,0.350250055,4.140523949,RFC5
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),0.273702394,0.350250055,4.140523949,HES5
Positive Regulation Of Cell Cycle (GO:0045787),0.273702394,0.350250055,4.140523949,EIF4EBP1
Regulation Of Cell-Matrix Adhesion (GO:0001952),0.273702394,0.350250055,4.140523949,BST1
Negative Regulation Of Endopeptidase Activity (GO:0010951),0.277272851,0.353668936,4.035840755,SERPINE1
Regulation Of Endocytosis (GO:0030100),0.277272851,0.353668936,4.035840755,DLL1
Neuropeptide Signaling Pathway (GO:0007218),0.284361726,0.360955933,3.837924991,GLRA2
Cell-Cell Junction Organization (GO:0045216),0.284361726,0.360955933,3.837924991,CDHR3
Telomere Maintenance (GO:0000723),0.284361726,0.360955933,3.837924991,BLM
Regulation Of Endopeptidase Activity (GO:0052548),0.287880311,0.364833825,3.744315415,SERPINE1
DNA Damage Response (GO:0006974),0.290901254,0.368069593,1.997842733,RFC5;BLM;POLD1
Sensory Organ Development (GO:0007423),0.291381772,0.368085802,3.65403968,OLIG1
Proteasomal Protein Catabolic Process (GO:0010498),0.293122335,0.369580666,2.308440409,PSMC3;USP44
Negative Regulation Of Protein Binding (GO:0032091),0.294866192,0.369580666,3.566937408,ITGA4
Cell-Cell Junction Assembly (GO:0007043),0.294866192,0.369580666,3.566937408,CDHR3
Kidney Development (GO:0001822),0.294866192,0.369580666,3.566937408,PRKX
Positive Regulation Of Multicellular Organismal Process (GO:0051240),0.294913162,0.369580666,1.959944803,COL1A1;SERPINE1;TMEM119
Response To Ionizing Radiation (GO:0010212),0.298333652,0.372089673,3.482857981,BLM
Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),0.298333652,0.372089673,3.482857981,COL1A2
Negative Regulation Of Cell Adhesion (GO:0007162),0.298333652,0.372089673,3.482857981,SERPINE1
Monocarboxylic Acid Transport (GO:0015718),0.301784233,0.375797772,3.401659824,GOT2
Regulation Of mRNA Stability (GO:0043488),0.305218019,0.379473271,3.323209744,NOCT
Cellular Response To Lipid (GO:0071396),0.307600484,0.380714443,2.138374672,SERPINE1;AKR1B1
Defense Response To Gram-negative Bacterium (GO:0050829),0.308635088,0.380714443,3.24738234,SERPINE1
Positive Regulation Of Neurogenesis (GO:0050769),0.308635088,0.380714443,3.24738234,BCAN
Regulation Of BMP Signaling Pathway (GO:0030510),0.308635088,0.380714443,3.24738234,HES5
Regulation Of DNA Replication (GO:0006275),0.308635088,0.380714443,3.24738234,BLM
Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),0.312035522,0.384306661,3.174059444,TAF4B
Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),0.315419402,0.385458182,3.103129621,ASPN
Positive Regulation Of JNK Cascade (GO:0046330),0.315419402,0.385458182,3.103129621,CCN2
Chloride Transport (GO:0006821),0.315419402,0.385458182,3.103129621,GLRA2
Embryonic Organ Development (GO:0048568),0.315419402,0.385458182,3.103129621,IGF2
Regulation Of T Cell Proliferation (GO:0042129),0.315419402,0.385458182,3.103129621,VCAM1
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),0.319097099,0.389347933,1.551013016,ZEB2;SATB1;IGF2;AKR1B1;HES5
Cellular Response To Oxygen-Containing Compound (GO:1901701),0.32039322,0.390324248,1.739105382,GLRA2;SERPINE1;RAPGEF3
Inflammatory Response (GO:0006954),0.322024226,0.390635531,1.984185485,VCAM1;HNRNPA0
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),0.322137814,0.390635531,2.968034374,BLM
Cellular Response To UV (GO:0034644),0.322137814,0.390635531,2.968034374,POLD1
Regulation Of Cytokinesis (GO:0032465),0.325472505,0.393466762,2.903675755,KLHL13
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),0.325472505,0.393466762,2.903675755,AKR1B1
Regulation Of Interleukin-8 Production (GO:0032677),0.328790959,0.396766433,2.841323066,SERPINE1
Regulation Of Inflammatory Response (GO:0050727),0.329210268,0.396766433,1.912452442,BST1;SERPINE1
Regulation Of Phosphorylation (GO:0042325),0.332093252,0.398410654,2.78089228,CD24
Sodium Ion Transmembrane Transport (GO:0035725),0.332093252,0.398410654,2.78089228,SLC4A4
Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),0.332093252,0.398410654,2.78089228,AKR1B1
Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.335379463,0.401740696,2.72230382,COL1A1
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),0.339951342,0.406462851,1.810967708,ZC4H2;AKR1B1
Calcium-Mediated Signaling (GO:0019722),0.341903949,0.406462851,2.610356116,VCAM1
Positive Regulation Of Amide Metabolic Process (GO:0034250),0.341903949,0.406462851,2.610356116,PASK
mRNA Metabolic Process (GO:0016071),0.341903949,0.406462851,2.610356116,HNRNPA0
Macromolecule Catabolic Process (GO:0009057),0.341903949,0.406462851,2.610356116,RNASEH2A
Negative Regulation Of Protein Kinase Activity (GO:0006469),0.351571988,0.416697522,2.45448841,DUSP10
Positive Regulation Of Cell Adhesion (GO:0045785),0.351571988,0.416697522,2.45448841,MAGI1
Organic Anion Transport (GO:0015711),0.354763322,0.418588807,2.405498549,SLC4A4
Sensory Perception Of Mechanical Stimulus (GO:0050954),0.354763322,0.418588807,2.405498549,COL1A1
Sodium Ion Transport (GO:0006814),0.354763322,0.418588807,2.405498549,SLC4A4
Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),0.357939108,0.42107336,2.357897086,RAPGEF3
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),0.357939108,0.42107336,2.357897086,PSMC3
Regulation Of Epithelial Cell Proliferation (GO:0050678),0.361099423,0.422894711,2.311631367,DUSP10
Positive Regulation Of MAP Kinase Activity (GO:0043406),0.361099423,0.422894711,2.311631367,CD24
Regulation Of RNA Metabolic Process (GO:0051252),0.361099423,0.422894711,2.311631367,SGF29
Sensory Perception Of Sound (GO:0007605),0.364244339,0.42531201,2.266651258,COL1A1
Positive Regulation Of Protein Catabolic Process (GO:0045732),0.364244339,0.42531201,2.266651258,PSMC3
Cellular Component Assembly (GO:0022607),0.364803957,0.425334392,1.599557071,MAGI1;HES5
Positive Regulation Of Protein Kinase B Signaling (GO:0051897),0.367373933,0.427697167,2.222909001,IGF2
"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",0.370488277,0.430050551,2.180359077,HNRNPA0
Cellular Response To Hormone Stimulus (GO:0032870),0.370488277,0.430050551,2.180359077,AKR1B1
Cell Junction Assembly (GO:0034329),0.373587445,0.432372528,2.13895808,CDHR3
Recombinational Repair (GO:0000725),0.373587445,0.432372528,2.13895808,BLM
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),0.37667151,0.435160655,2.098664596,COL1A2
Negative Regulation Of Signal Transduction (GO:0009968),0.377102372,0.435160655,1.505562901,CHAC1;CXXC4
Regulation Of Defense Response (GO:0031347),0.379740546,0.437563411,2.059439097,BST1
Axon Development (GO:0061564),0.385833817,0.443286444,1.984042737,OLIG1
Cellular Response To Insulin Stimulus (GO:0032869),0.385833817,0.443286444,1.984042737,IGF2
Chemical Synaptic Transmission (GO:0007268),0.387567449,0.44416749,1.430469353,GLRA2;CDHR3
Regulation Of Organelle Organization (GO:0033043),0.388858196,0.44416749,1.947801335,ZEB2
Response To UV (GO:0009411),0.388858196,0.44416749,1.947801335,POLD1
Protein Complex Oligomerization (GO:0051259),0.388858196,0.44416749,1.947801335,BLM
Regulation Of RNA Splicing (GO:0043484),0.394862801,0.450372499,1.878067176,SGF29
Positive Regulation Of Inflammatory Response (GO:0050729),0.400809004,0.456493034,1.811794309,SERPINE1
Monoatomic Cation Transmembrane Transport (GO:0098655),0.401402522,0.456508359,1.337491723,KCNN3;SLC4A4
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),0.403760382,0.458527302,1.779884339,CCN2
Inorganic Cation Transmembrane Transport (GO:0098662),0.406553884,0.461034447,1.304577521,KCNN3;SLC4A4
Regulation Of Transcription By RNA Polymerase II (GO:0006357),0.408497491,0.461849526,1.003714669,ZEB2;PSMC3;SATB1;LMO3;IGF2;AKR1B1;OLIG1;SGF29;DLL1;HES5;VGLL3
Regulation Of Cellular Response To Stress (GO:0080135),0.409620037,0.461849526,1.718384613,SGF29
Negative Regulation Of Translation (GO:0017148),0.409620037,0.461849526,1.718384613,EIF4EBP1
Positive Regulation Of T Cell Activation (GO:0050870),0.409620037,0.461849526,1.718384613,VCAM1
Positive Regulation Of Translation (GO:0045727),0.412528454,0.463799847,1.68874503,PASK
Lipid Transport (GO:0006869),0.412528454,0.463799847,1.68874503,GOT2
Regulation Of Wnt Signaling Pathway (GO:0030111),0.415422688,0.466387525,1.659814104,CXXC4
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),0.418302808,0.468952008,1.631569374,ADGRL4
RNA Metabolic Process (GO:0016070),0.421168882,0.470823736,1.603989277,RNASEH2A
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),0.421168882,0.470823736,1.603989277,ASPN
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),0.424020978,0.472669277,1.577053103,BLM
Small GTPase Mediated Signal Transduction (GO:0007264),0.424020978,0.472669277,1.577053103,RAPGEF3
Regulation Of MAP Kinase Activity (GO:0043405),0.429683505,0.478303987,1.525033707,CD24
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),0.438074138,0.484900628,1.451360986,SERPINE1
Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),0.438074138,0.484900628,1.451360986,CD24
Protein Maturation (GO:0051604),0.438074138,0.484900628,1.451360986,MMP16
Protein Processing (GO:0016485),0.438074138,0.484900628,1.451360986,MMP16
Potassium Ion Transport (GO:0006813),0.451787832,0.497979025,1.33908557,KCNN3
Protein Localization To Nucleus (GO:0034504),0.451787832,0.497979025,1.33908557,COL1A1
Receptor-Mediated Endocytosis (GO:0006898),0.451787832,0.497979025,1.33908557,DLL1
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),0.454490552,0.499558749,1.318072998,THBS4
Regulation Of Cell Motility (GO:2000145),0.454490552,0.499558749,1.318072998,PRKX
Cellular Response To Lipopolysaccharide (GO:0071222),0.457180084,0.49972323,1.297509545,SERPINE1
Positive Regulation Of Defense Response (GO:0031349),0.457180084,0.49972323,1.297509545,SERPINE1
Protein Dephosphorylation (GO:0006470),0.457180084,0.49972323,1.297509545,DUSP10
Regulation Of DNA Metabolic Process (GO:0051052),0.457180084,0.49972323,1.297509545,SGF29
Regulation Of Mitotic Cell Cycle (GO:0007346),0.459856489,0.501951535,1.277382582,EIF4EBP1
Positive Regulation Of Intracellular Protein Transport (GO:0090316),0.462519833,0.50415943,1.25767993,RAPGEF3
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),0.464992359,0.505647692,0.985601103,PSMC3;USP44
Regulation Of Response To External Stimulus (GO:0032101),0.465170177,0.505647692,1.238389832,BST1
Protein Homooligomerization (GO:0051260),0.470432119,0.509958785,1.201002309,BLM
Regulation Of DNA Repair (GO:0006282),0.470432119,0.509958785,1.201002309,SGF29
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),0.473043842,0.511381186,1.182883351,COL1A2
Regulation Of Cell Cycle Process (GO:0010564),0.473043842,0.511381186,1.182883351,KLHL13
Synapse Organization (GO:0050808),0.475642815,0.513485453,1.165133849,ZC4H2
Regulation Of Gene Expression (GO:0010468),0.477682236,0.514864981,0.807251798,NOCT;IGF2;TMEM119;AKR1B1;SGF29;DLL1
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),0.478229099,0.514864981,1.14774393,BICDL1
Proteolysis (GO:0006508),0.482667242,0.518933223,0.905630451,MMP16;PAPPA
Cellular Response To Metal Ion (GO:0071248),0.485912436,0.521709532,1.09763781,GLRA2
Regulation Of Protein Kinase B Signaling (GO:0051896),0.488448578,0.523718026,1.081593901,IGF2
Potassium Ion Transmembrane Transport (GO:0071805),0.490972336,0.524993517,1.06586491,KCNN3
Protein Localization To Organelle (GO:0033365),0.490972336,0.524993517,1.06586491,COL1A1
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.4984699,0.532287396,1.020487963,CXXC4
Negative Regulation Of Response To External Stimulus (GO:0032102),0.513138635,0.546468344,0.937223795,SERPINE1
Positive Regulation Of Cellular Catabolic Process (GO:0031331),0.513138635,0.546468344,0.937223795,SLC4A4
Dephosphorylation (GO:0016311),0.515541793,0.548285664,0.924239451,DUSP10
Neuron Development (GO:0048666),0.522681044,0.555128181,0.886696711,BICDL1
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),0.52738259,0.559366709,0.862788483,AKR1B1
Regulation Of Cellular Component Organization (GO:0051128),0.529716144,0.561085607,0.851154799,TMEM97
Positive Regulation Of Response To External Stimulus (GO:0032103),0.534349093,0.565232173,0.828503717,SERPINE1
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),0.539433838,0.569844873,0.688294685,PSMC3;USP44
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),0.55243343,0.582014872,0.745459909,ADGRL4
Nitrogen Compound Transport (GO:0071705),0.55243343,0.582014872,0.745459909,SLC38A1
Double-Strand Break Repair (GO:0006302),0.563381281,0.592755438,0.699050334,BLM
Brain Development (GO:0007420),0.56553883,0.594231053,0.690225376,HES5
Negative Regulation Of DNA-templated Transcription (GO:0045892),0.568583234,0.59663334,0.561929162,ZEB2;SATB1;IGF2;AKR1B1;HES5
Metal Ion Transport (GO:0030001),0.569822319,0.59713737,0.673006812,SLC4A4
Generation Of Neurons (GO:0048699),0.571948361,0.598568298,0.664607181,DCX
Positive Regulation Of Hydrolase Activity (GO:0051345),0.580349025,0.606553363,0.632339646,RAPGEF3
Negative Regulation Of Cytokine Production (GO:0001818),0.584487953,0.610068991,0.616966738,DLL1
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),0.586542239,0.611402307,0.609461541,CCN2
RNA Processing (GO:0006396),0.594659336,0.618225756,0.580593463,HNRNPA0
Macromolecule Biosynthetic Process (GO:0009059),0.594659336,0.618225756,0.580593463,POLD1
Phosphate-Containing Compound Metabolic Process (GO:0006796),0.59666384,0.619491349,0.573653277,DUSP10
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),0.60064346,0.622801585,0.560089996,NOCT
Regulation Of DNA-templated Transcription (GO:0006355),0.607421946,0.62900141,0.47406429,COL1A1;BLM;ZEB2;SATB1;IGF2;AKR1B1;SGF29;HES5;VGLL3
Protein Localization To Membrane (GO:0072657),0.612350603,0.633271911,0.521793355,ITGA4
Positive Regulation Of Protein Metabolic Process (GO:0051247),0.61996598,0.640306071,0.498109062,PASK
Phosphorylation (GO:0016310),0.624681069,0.644330277,0.447075581,TAF4B;PASK
Anterograde Trans-Synaptic Signaling (GO:0098916),0.62558016,0.644413071,0.481238656,GLRA2
Regulation Of Translation (GO:0006417),0.631112237,0.64926187,0.465087451,PASK
Defense Response To Bacterium (GO:0042742),0.634755262,0.652157169,0.454700428,SERPINE1
mRNA Processing (GO:0006397),0.652443021,0.668379415,0.406941706,HNRNPA0
Regulation Of GTPase Activity (GO:0043087),0.652443021,0.668379415,0.406941706,RAPGEF3
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.653092465,0.668379415,0.38366959,IGF2;SGF29
Positive Regulation Of Cell Motility (GO:2000147),0.664317307,0.678984053,0.377218692,COL1A1
Protein Polyubiquitination (GO:0000209),0.672552217,0.686509202,0.35763502,UBE2QL1
Regulation Of Cell Growth (GO:0001558),0.674175042,0.687140383,0.353871357,TMEM97
Apoptotic Process (GO:0006915),0.675789906,0.687140383,0.350156777,AKAP1
Chromatin Remodeling (GO:0006338),0.675789906,0.687140383,0.350156777,SATB1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.680587118,0.691125242,0.339299626,DUSP10
Positive Regulation Of GTPase Activity (GO:0043547),0.685314061,0.695028565,0.328856405,RAPGEF3
Chromatin Organization (GO:0006325),0.734280087,0.743730281,0.2341619,SATB1
Positive Regulation Of Cell Migration (GO:0030335),0.739520104,0.748074964,0.225348236,COL1A1
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),0.754634223,0.762383996,0.201201504,IGF2
Regulation Of Cell Cycle (GO:0051726),0.771173112,0.778093897,0.176827043,SGF29
Positive Regulation Of Cytokine Production (GO:0001819),0.794960157,0.801067405,0.145221196,SERPINE1
Negative Regulation Of Gene Expression (GO:0010629),0.810706145,0.815889688,0.126361829,NOCT
Protein Localization (GO:0008104),0.824378396,0.82858978,0.111222163,FBLN5
Protein Modification By Small Protein Conjugation (GO:0032446),0.835433904,0.838630717,0.099775389,KLHL13
Protein Modification Process (GO:0036211),0.86779868,0.870009632,0.07996831,TAF4B;PASK
Negative Regulation Of Apoptotic Process (GO:0043066),0.908972839,0.910129293,0.039726976,DLL1
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),0.926705746,0.926705746,0.029020179,IGF2
Rough Endoplasmic Reticulum Membrane (GO:0030867),0.023036898,0.562733828,203.9331744,RPS29
Alveolar Lamellar Body (GO:0097208),0.023036898,0.562733828,203.9331744,CTSH
Exocytic Vesicle Membrane (GO:0099501),0.025279588,0.562733828,31.46975356,MCTP1;SV2C
Synaptic Vesicle Membrane (GO:0030672),0.026173666,0.562733828,30.5713416,MCTP1;SV2C
Lamellar Body (GO:0042599),0.058808769,0.708612989,51.06138806,CTSH
Cytoplasmic Side Of Endoplasmic Reticulum Membrane (GO:0098554),0.058808769,0.708612989,51.06138806,RPS29
Protein Kinase Complex (GO:1902911),0.076205688,0.708612989,34.78653722,INSRR
Sodium Channel Complex (GO:0034706),0.080504977,0.708612989,32.04065686,SCNN1G
Cul2-RING Ubiquitin Ligase Complex (GO:0031462),0.101706309,0.708612989,22.45576451,ZSWIM6
Polysomal Ribosome (GO:0042788),0.122423928,0.708612989,16.80888767,RPS29
MLL1 Complex (GO:0071339),0.13057799,0.708612989,15.16766359,MGAM
MLL1/2 Complex (GO:0044665),0.134626869,0.708612989,14.44142017,MGAM
Recycling Endosome (GO:0055037),0.168998767,0.708612989,4.915351187,MCTP1;AVL9
Brush Border Membrane (GO:0031526),0.17023749,0.708612989,9.804209131,SLC20A2
Tertiary Granule (GO:0070820),0.173956411,0.708612989,4.744028297,MGAM;CTSH
Cytosolic Small Ribosomal Subunit (GO:0022627),0.174103612,0.708612989,9.437390164,RPS29
Small Ribosomal Subunit (GO:0015935),0.177951914,0.708612989,9.091601765,RPS29
Voltage-Gated Calcium Channel Complex (GO:0005891),0.204397826,0.708612989,7.139917855,CACNA1E
Multivesicular Body (GO:0005771),0.208106457,0.708612989,6.914643338,CTSH
Ficolin-1-Rich Granule (GO:0101002),0.21093942,0.708612989,3.706766719,MGAM;CTSH
Endoplasmic reticulum-Golgi Intermediate Compartment Membrane (GO:0033116),0.21547249,0.708612989,6.495612095,F5
Cation Channel Complex (GO:0034703),0.219130047,0.708612989,6.300517359,SCNN1G
Tertiary Granule Lumen (GO:1904724),0.219130047,0.708612989,6.300517359,CTSH
Extracellular Membrane-Bounded Organelle (GO:0065010),0.233592349,0.708612989,5.603044078,F5
Calcium Channel Complex (GO:0034704),0.240723814,0.708612989,5.297425077,CACNA1E
cis-Golgi Network (GO:0005801),0.244264889,0.708612989,5.153978689,B3GAT3
Extracellular Vesicle (GO:1903561),0.244264889,0.708612989,5.153978689,F5
Ficolin-1-Rich Granule Membrane (GO:0101003),0.244264889,0.708612989,5.153978689,MGAM
Ribosome (GO:0005840),0.247789626,0.708612989,5.016311897,RPS29
Platelet Alpha Granule Lumen (GO:0031093),0.265170842,0.708612989,4.404329985,F5
Vesicle Membrane (GO:0012506),0.275408236,0.708612989,4.08925929,SPIRE1
Lytic Vacuole (GO:0000323),0.277924824,0.708612989,2.506692389,CTSH;BBC3
Tertiary Granule Membrane (GO:0070821),0.285504519,0.708612989,3.806548511,MGAM
Motile Cilium (GO:0031514),0.288838921,0.708612989,3.718721471,CABYR
COPII-coated ER To Golgi Transport Vesicle (GO:0030134),0.298750044,0.708612989,3.472462566,F5
Cytoplasmic Stress Granule (GO:0010494),0.298750044,0.708612989,3.472462566,HABP4
Coated Vesicle (GO:0030135),0.308524504,0.708612989,3.249441477,F5
Bicellular Tight Junction (GO:0005923),0.314965809,0.708612989,3.112222607,CGNL1
P-body (GO:0000932),0.321347751,0.708612989,2.983293033,WTIP
Platelet Alpha Granule (GO:0031091),0.340142781,0.73130698,2.639897176,F5
Tight Junction (GO:0070160),0.352385777,0.739150653,2.441825925,CGNL1
Secretory Granule Membrane (GO:0030667),0.373210888,0.763532026,1.535093937,MGAM;SELL
Cell Projection Membrane (GO:0031253),0.387782461,0.763532026,1.960660018,SLC20A2
Apical Junction Complex (GO:0043296),0.390644292,0.763532026,1.926816333,CGNL1
Cytoplasmic Vesicle Lumen (GO:0060205),0.415812423,0.782496426,1.656061563,CTSH
Early Endosome Membrane (GO:0031901),0.4185446,0.782496426,1.629326496,LDLRAD4
Secretory Granule Lumen (GO:0034774),0.433503465,0.78353006,1.146280997,CTSH;F5
Ficolin-1-Rich Granule Lumen (GO:1904813),0.437319103,0.78353006,1.457948853,CTSH
Mitotic Spindle (GO:0072686),0.487719242,0.812115253,1.086311517,LIMK2
Mitochondrial Matrix (GO:0005759),0.49362248,0.812115253,0.859497327,AMT;METTL15
Adherens Junction (GO:0005912),0.504282351,0.812115253,0.986774231,WTIP
Mitochondrial Outer Membrane (GO:0005741),0.506604851,0.812115253,0.973567643,SPIRE1
Bounding Membrane Of Organelle (GO:0098588),0.532049379,0.812115253,0.6643642,SELL;B3GAT3;LDLRAD4;F5
Focal Adhesion (GO:0005925),0.539900166,0.812115253,0.686901404,RPS29;TNS2
Cytoplasmic Vesicle Membrane (GO:0030659),0.542695811,0.812115253,0.677556141,SELL;SPIRE1
Membrane Raft (GO:0045121),0.546616048,0.812115253,0.771385007,MAL
Organelle Outer Membrane (GO:0031968),0.548742244,0.812115253,0.761853347,SPIRE1
Cell-Substrate Junction (GO:0030055),0.551013102,0.812115253,0.650408491,RPS29;TNS2
cullin-RING Ubiquitin Ligase Complex (GO:0031461),0.557148837,0.812115253,0.72523673,ZSWIM6
Intracellular Organelle Lumen (GO:0070013),0.567345892,0.813195778,0.569716178,AMT;CTSH;METTL15;F5
Golgi Membrane (GO:0000139),0.593586394,0.836859507,0.525469973,B3GAT3;LDLRAD4
Axon (GO:0030424),0.617256024,0.854763221,0.506507556,INSRR
Spindle (GO:0005819),0.626163755,0.854763221,0.479586425,LIMK2
Nuclear Membrane (GO:0031965),0.65494337,0.880080154,0.400592883,HABP4
Vesicle (GO:0031982),0.667717281,0.883441325,0.369088461,F5
Lysosome (GO:0005764),0.682567082,0.889405591,0.325109958,CTSH;BBC3
Cilium (GO:0005929),0.70048314,0.891923333,0.297021947,CABYR
Dendrite (GO:0030425),0.718320268,0.891923333,0.262527521,HTR2A
Mitochondrial Membrane (GO:0031966),0.719869844,0.891923333,0.260071775,SPIRE1;SPG7
Neuron Projection (GO:0043005),0.735752214,0.891923333,0.235160525,INSRR;HTR2A
Endoplasmic Reticulum Lumen (GO:0005788),0.73635531,0.891923333,0.230672084,F5
Cell-Cell Junction (GO:0005911),0.754411993,0.896921836,0.201566337,WTIP
Early Endosome (GO:0005769),0.763536264,0.896921836,0.18784616,LDLRAD4
Cytoskeleton (GO:0005856),0.771769952,0.896921836,0.184166908,CDC42EP2;TTC17
Actin Cytoskeleton (GO:0015629),0.78490578,0.900025295,0.158120619,TTC17
Microtubule Cytoskeleton (GO:0015630),0.799668432,0.900360368,0.13942808,CDC42EP2
Endosome Membrane (GO:0010008),0.816936544,0.900360368,0.119332226,LDLRAD4
Mitochondrial Inner Membrane (GO:0005743),0.824593875,0.900360368,0.110998658,SPG7
Collagen-Containing Extracellular Matrix (GO:0062023),0.827075222,0.900360368,0.108371549,CTSH
Organelle Inner Membrane (GO:0019866),0.846447232,0.909930774,0.089049986,SPG7
Endoplasmic Reticulum Membrane (GO:0005789),0.891526528,0.94655903,0.060349673,CYP2J2;MCTP1
Nucleolus (GO:0005730),0.974385818,0.99709233,0.007009679,HABP4
Nuclear Lumen (GO:0031981),0.975479548,0.99709233,0.006626017,HABP4
Intracellular Non-Membrane-Bounded Organelle (GO:0043232),0.977764468,0.99709233,0.007752398,HABP4;EIF4G3
Intracellular Membrane-Bounded Organelle (GO:0043231),0.99113507,0.99709233,0.004893934,CYP2J2;B3GAT3;LIMK2;LDLRAD4;C6ORF52;GATA2;WTIP;CUX2;CABYR;LMX1A;ADI1;ATOH8;HABP4;CTSH;OTX1
Nucleus (GO:0005634),0.99709233,0.99709233,0.001346667,CUX2;CABYR;LMX1A;ADI1;LIMK2;ATOH8;HABP4;C6ORF52;OTX1;GATA2;WTIP
Cellular Response To pH (GO:0071467),0.003848558,0.351646109,135.0231581,SCNN1G;INSRR
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),0.006837874,0.351646109,41.18463146,HTR2A;NALF1;CACNA1E
Actin Filament Polymerization (GO:0030041),0.009111723,0.351646109,70.77733247,SPIRE1;TTC17
Inorganic Cation Import Across Plasma Membrane (GO:0098659),0.012315424,0.351646109,29.02981795,SCNN1G;NALF1;CACNA1E
Calcium Ion Import Across Plasma Membrane (GO:0098703),0.012817171,0.351646109,54.36841348,CACNA1E;NALF1
Positive Regulation Of miRNA Transcription (GO:1902895),0.017068398,0.351646109,43.3476717,ATOH8;GATA2
Positive Regulation Of miRNA Metabolic Process (GO:2000630),0.021833138,0.351646109,35.51607276,ATOH8;GATA2
Regulation Of Epithelial Cell Migration (GO:0010632),0.022674995,0.351646109,34.43038199,CTSH;PTPRG
Epithelial Tube Branching Involved In Lung Morphogenesis (GO:0060441),0.023036898,0.351646109,203.9331744,CTSH
Forebrain Neuron Differentiation (GO:0021879),0.023036898,0.351646109,203.9331744,ZSWIM6
PML Body Organization (GO:0030578),0.023036898,0.351646109,203.9331744,HABP4
Bradykinin Catabolic Process (GO:0010815),0.023036898,0.351646109,203.9331744,CTSH
Actin Polymerization Or Depolymerization (GO:0008154),0.025279588,0.351646109,31.46975356,SPIRE1;TTC17
Glucan Catabolic Process (GO:0009251),0.027580896,0.351646109,155.3494713,MGAM
Vascular Wound Healing (GO:0061042),0.027580896,0.351646109,155.3494713,GATA2
Positive Regulation Of Phospholipid Biosynthetic Process (GO:0071073),0.027580896,0.351646109,155.3494713,HTR2A
Parallel Actin Filament Bundle Assembly (GO:0030046),0.027580896,0.351646109,155.3494713,SPIRE1
Cleavage Furrow Formation (GO:0036089),0.027580896,0.351646109,155.3494713,SPIRE1
Actin Filament Organization (GO:0007015),0.02964221,0.351646109,16.44155471,CDC42EP2;SPIRE1;CGNL1
Positive Regulation Of Mitochondrion Organization (GO:0010822),0.029875772,0.351646109,27.35127681,SPIRE1;BBC3
Regulation Of miRNA Transcription (GO:1902893),0.030832079,0.351646109,26.62892318,ATOH8;GATA2
Negative Regulation Of Neural Precursor Cell Proliferation (GO:2000178),0.032103986,0.351646109,123.9765628,GATA2
Fat Cell Differentiation (GO:0045444),0.033772773,0.351646109,24.63136523,METRNL;GATA2
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),0.033772773,0.351646109,24.63136523,CTSH;BBC3
Protein Polymerization (GO:0051258),0.034776499,0.351646109,24.01693806,SPIRE1;TTC17
Regulation Of Endothelial Cell Differentiation (GO:0045601),0.036606265,0.351646109,102.204913,ATOH8
T Cell Mediated Cytotoxicity (GO:0001913),0.036606265,0.351646109,102.204913,CTSH
Actin Filament Network Formation (GO:0051639),0.036606265,0.351646109,102.204913,SPIRE1
Astral Microtubule Organization (GO:0030953),0.036606265,0.351646109,102.204913,LIMK2
Brown Fat Cell Differentiation (GO:0050873),0.036606265,0.351646109,102.204913,METRNL
Positive Regulation Of Blood Vessel Endothelial Cell Proliferation Involved In Sprouting Angiogenesis (GO:1903589),0.036606265,0.351646109,102.204913,GATA2
Sensory Perception Of Sour Taste (GO:0050915),0.036606265,0.351646109,102.204913,SCNN1G
Positive Regulation Of Dendritic Spine Morphogenesis (GO:0061003),0.036606265,0.351646109,102.204913,CUX2
Negative Regulation Of Cholesterol Storage (GO:0010887),0.036606265,0.351646109,102.204913,TTC39B
Regulation Of Translational Initiation (GO:0006446),0.036818425,0.351646109,22.85716507,HABP4;EIF4G3
Negative Regulation Of Cell Migration (GO:0030336),0.040494709,0.351646109,13.19175282,MCTP1;LDLRAD4;PTPRG
G Protein-Coupled Serotonin Receptor Signaling Pathway (GO:0098664),0.041087826,0.351646109,86.3022715,HTR2A
Toxin Transport (GO:1901998),0.041087826,0.351646109,86.3022715,RAB40B
Positive Regulation Of miRNA-mediated Gene Silencing (GO:2000637),0.041087826,0.351646109,86.3022715,WTIP
Positive Regulation Of Mitochondrial Membrane Permeability (GO:0035794),0.041087826,0.351646109,86.3022715,SPG7
Apical Protein Localization (GO:0045176),0.041087826,0.351646109,86.3022715,MAL
Cell Differentiation In Spinal Cord (GO:0021515),0.041087826,0.351646109,86.3022715,DRAXIN
Chondroitin Sulfate Proteoglycan Metabolic Process (GO:0050654),0.041087826,0.351646109,86.3022715,B3GAT3
Surfactant Homeostasis (GO:0043129),0.045548763,0.351646109,74.23232018,CTSH
Positive Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901030),0.045548763,0.351646109,74.23232018,BBC3
Negative Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060394),0.045548763,0.351646109,74.23232018,LDLRAD4
Positive Regulation Of Post-Transcriptional Gene Silencing By RNA (GO:1900370),0.045548763,0.351646109,74.23232018,WTIP
Angiogenesis Involved In Wound Healing (GO:0060055),0.045548763,0.351646109,74.23232018,GATA2
Phosphate Ion Transmembrane Transport (GO:0035435),0.045548763,0.351646109,74.23232018,SLC20A2
Midbrain Dopaminergic Neuron Differentiation (GO:1904948),0.045548763,0.351646109,74.23232018,LMX1A
Mitochondrial Protein Processing (GO:0034982),0.045548763,0.351646109,74.23232018,SPG7
rRNA Base Methylation (GO:0070475),0.045548763,0.351646109,74.23232018,METTL15
Positive Regulation Of Pseudopodium Assembly (GO:0031274),0.04998917,0.351646109,64.79390764,CDC42EP2
Regulation Of Pseudopodium Assembly (GO:0031272),0.04998917,0.351646109,64.79390764,CDC42EP2
Regulation Of Response To Oxidative Stress (GO:1902882),0.04998917,0.351646109,64.79390764,MCTP1
Cellular Response To Thyroid Hormone Stimulus (GO:0097067),0.04998917,0.351646109,64.79390764,CTSH
Negative Regulation Of Cell Division (GO:0051782),0.04998917,0.351646109,64.79390764,SUSD2
Proteolysis Involved In Protein Catabolic Process (GO:0051603),0.051147264,0.351646109,17.04987877,CTSH;ANKZF1
Negative Regulation Of Hippo Signaling (GO:0035331),0.054409141,0.351646109,57.23487629,WTIP
Nuclear Body Organization (GO:0030575),0.054409141,0.351646109,57.23487629,HABP4
Cellular Response To Acidic pH (GO:0071468),0.054409141,0.351646109,57.23487629,SCNN1G
Positive Regulation Of Cell Morphogenesis Involved In Differentiation (GO:0010770),0.054409141,0.351646109,57.23487629,CUX2
Response To Thyroid Hormone (GO:0097066),0.054409141,0.351646109,57.23487629,CTSH
Negative Regulation Of Cell Cycle Phase Transition (GO:1901988),0.054409141,0.351646109,57.23487629,SUSD2
Extracellular Transport (GO:0006858),0.058808769,0.351646109,51.06138806,CABYR
Microtubule-Based Transport (GO:0099111),0.058808769,0.351646109,51.06138806,CABYR
Positive Regulation Of Brown Fat Cell Differentiation (GO:0090336),0.058808769,0.351646109,51.06138806,METRNL
Positive Regulation Of Endothelial Cell Migration (GO:0010595),0.059560435,0.351646109,14.80704907,ATOH8;GATA2
Regulation Of Cholesterol Storage (GO:0010885),0.063188145,0.351646109,45.93648646,TTC39B
Negative Regulation Of Cilium Assembly (GO:1902018),0.063188145,0.351646109,45.93648646,LIMK2
Regulation Of miRNA-mediated Gene Silencing (GO:0060964),0.067547363,0.351646109,41.62280132,WTIP
Protein Localization To Cell-Cell Junction (GO:0150105),0.067547363,0.351646109,41.62280132,CGNL1
Positive Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090050),0.071886513,0.351646109,37.94855382,GATA2
Regulation Of Blood Vessel Endothelial Cell Proliferation Involved In Sprouting Angiogenesis (GO:1903587),0.071886513,0.351646109,37.94855382,GATA2
Positive Regulation Of Epithelial Cell Migration (GO:0010634),0.072331482,0.351646109,12.29856743,ATOH8;CTSH
Positive Regulation Of Gene Expression (GO:0010628),0.073154466,0.351646109,6.078734291,CUX2;HABP4;CTSH;GATA2;EIF4G3
Epoxygenase P450 Pathway (GO:0019373),0.076205688,0.351646109,34.78653722,CYP2J2
Leukocyte Tethering Or Rolling (GO:0050901),0.076205688,0.351646109,34.78653722,SELL
Microtubule Depolymerization (GO:0007019),0.076205688,0.351646109,34.78653722,NCKAP5
Response To Acidic pH (GO:0010447),0.076205688,0.351646109,34.78653722,SCNN1G
Regulation Of Brown Fat Cell Differentiation (GO:0090335),0.076205688,0.351646109,34.78653722,METRNL
Positive Regulation Of Dendrite Morphogenesis (GO:0050775),0.076205688,0.351646109,34.78653722,CUX2
Sensory Perception Of Taste (GO:0050909),0.076205688,0.351646109,34.78653722,SCNN1G
Establishment Of Vesicle Localization (GO:0051650),0.080504977,0.351646109,32.04065686,LIMK2
Negative Regulation Of Lipid Storage (GO:0010888),0.080504977,0.351646109,32.04065686,TTC39B
Regulation Of Mitochondrial Membrane Permeability (GO:0046902),0.080504977,0.351646109,32.04065686,SPG7
Intracellular Sodium Ion Homeostasis (GO:0006883),0.080504977,0.351646109,32.04065686,SCNN1G
ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),0.080504977,0.351646109,32.04065686,WTIP
Positive Regulation Of Vasculature Development (GO:1904018),0.084505068,0.351646109,10.54450364,CTSH;GATA2
Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090287),0.084784473,0.351646109,29.63704635,FSTL4
Positive Regulation Of Mitochondrial Fission (GO:0090141),0.084784473,0.351646109,29.63704635,SPIRE1
Leukocyte Adhesion To Vascular Endothelial Cell (GO:0061756),0.084784473,0.351646109,29.63704635,SELL
Linoleic Acid Metabolic Process (GO:0043651),0.084784473,0.351646109,29.63704635,CYP2J2
Phosphate Ion Transport (GO:0006817),0.084784473,0.351646109,29.63704635,SLC20A2
Release Of Cytochrome C From Mitochondria (GO:0001836),0.084784473,0.351646109,29.63704635,BBC3
Multicellular Organismal-Level Water Homeostasis (GO:0050891),0.084784473,0.351646109,29.63704635,SCNN1G
Chondroitin Sulfate Proteoglycan Biosynthetic Process (GO:0050650),0.084784473,0.351646109,29.63704635,B3GAT3
Dopaminergic Neuron Differentiation (GO:0071542),0.084784473,0.351646109,29.63704635,LMX1A
Monoatomic Ion Transport (GO:0006811),0.088693014,0.351646109,10.04119587,SLC20A2;TRPM3
Epithelial Cilium Movement Involved In Extracellular Fluid Movement (GO:0003351),0.089044264,0.351646109,27.51804806,CABYR
T Cell Mediated Immunity (GO:0002456),0.089044264,0.351646109,27.51804806,CTSH
Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),0.089044264,0.351646109,27.51804806,CGNL1
Positive Regulation Of Epithelial Cell Differentiation (GO:0030858),0.089044264,0.351646109,27.51804806,ATOH8
Positive Regulation Of Translation (GO:0045727),0.090102633,0.351646109,9.88122816,HABP4;EIF4G3
Sulfur Compound Transport (GO:0072348),0.093284441,0.351646109,25.63803881,SLC35F3
Aminoglycan Biosynthetic Process (GO:0006023),0.093284441,0.351646109,25.63803881,B3GAT3
Positive Regulation Of Translational Initiation (GO:0045948),0.093284441,0.351646109,25.63803881,HABP4
Regulation Of Neurotransmitter Transport (GO:0051588),0.093284441,0.351646109,25.63803881,MCTP1
Peptide Catabolic Process (GO:0043171),0.093284441,0.351646109,25.63803881,CTSH
Regulation Of Steroid Metabolic Process (GO:0019218),0.093284441,0.351646109,25.63803881,TTC39B
Positive Regulation Of Dendritic Spine Development (GO:0060999),0.093284441,0.351646109,25.63803881,CUX2
Sodium Ion Import Across Plasma Membrane (GO:0098719),0.093284441,0.351646109,25.63803881,SCNN1G
Regulation Of Neural Precursor Cell Proliferation (GO:2000177),0.097505093,0.351646109,23.96047534,GATA2
rRNA Methylation (GO:0031167),0.097505093,0.351646109,23.96047534,METTL15
Positive Regulation Of Excitatory Postsynaptic Potential (GO:2000463),0.097505093,0.351646109,23.96047534,CUX2
Regulation Of Cholesterol Metabolic Process (GO:0090181),0.101706309,0.351646109,22.45576451,TTC39B
Regulation Of Cholesterol Transport (GO:0032374),0.101706309,0.351646109,22.45576451,TTC39B
Protein Localization To Cell Junction (GO:1902414),0.101706309,0.351646109,22.45576451,CGNL1
Rescue Of Stalled Ribosome (GO:0072344),0.101706309,0.351646109,22.45576451,ANKZF1
Protein Processing (GO:0016485),0.10307838,0.351646109,8.59487452,CTSH;SPG7
ERK1 And ERK2 Cascade (GO:0070371),0.105888176,0.351646109,21.09970251,CTSH
Positive Regulation Of Angiogenesis (GO:0045766),0.106028698,0.351646109,8.342192205,CTSH;GATA2
Regulation Of Hippo Signaling (GO:0035330),0.110050785,0.351646109,19.87231415,WTIP
Positive Regulation Of Peptidase Activity (GO:0010952),0.110050785,0.351646109,19.87231415,CTSH
Negative Regulation Of Stress Fiber Assembly (GO:0051497),0.110050785,0.351646109,19.87231415,CGNL1
Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),0.110050785,0.351646109,19.87231415,BBC3
Metanephros Development (GO:0001656),0.110050785,0.351646109,19.87231415,CTSH
Sodium Ion Homeostasis (GO:0055078),0.110050785,0.351646109,19.87231415,SCNN1G
Protein Dephosphorylation (GO:0006470),0.113502847,0.351646109,7.755489605,TNS2;PTPRG
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),0.113502847,0.351646109,7.755489605,INSRR;PTPRG
Negative Regulation Of Endothelial Cell Apoptotic Process (GO:2000352),0.114194221,0.351646109,18.75697777,GATA2
Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),0.114194221,0.351646109,18.75697777,TNS2
Telomere Maintenance Via Telomere Lengthening (GO:0010833),0.114194221,0.351646109,18.75697777,ZBTB48
miRNA-mediated Gene Silencing (GO:0035195),0.114194221,0.351646109,18.75697777,WTIP
Plasma Membrane Invagination (GO:0099024),0.114194221,0.351646109,18.75697777,SPIRE1
Positive Regulation Of Intracellular Protein Transport (GO:0090316),0.116530121,0.351646109,7.537335229,B3GAT3;BBC3
Activation Of Phospholipase C Activity (GO:0007202),0.118318573,0.351646109,17.73975745,HTR2A
Regulation Of Mitochondrial Fission (GO:0090140),0.118318573,0.351646109,17.73975745,SPIRE1
Regulation Of Peptidase Activity (GO:0052547),0.118318573,0.351646109,17.73975745,CTSH
Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),0.118318573,0.351646109,17.73975745,ANKZF1
Microtubule Polymerization Or Depolymerization (GO:0031109),0.118318573,0.351646109,17.73975745,NCKAP5
Negative Regulation Of Notch Signaling Pathway (GO:0045746),0.118318573,0.351646109,17.73975745,GATA2
Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),0.118318573,0.351646109,17.73975745,TNS2
Glycosaminoglycan Metabolic Process (GO:0030203),0.122423928,0.354155217,16.80888767,B3GAT3
Protein Depolymerization (GO:0051261),0.122423928,0.354155217,16.80888767,NCKAP5
Negative Regulation Of Actin Filament Bundle Assembly (GO:0032232),0.122423928,0.354155217,16.80888767,CGNL1
Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),0.126510371,0.354155217,15.95437137,LIMK2
Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.126510371,0.354155217,15.95437137,TNS2
Negative Regulation Of DNA Binding (GO:0043392),0.126510371,0.354155217,15.95437137,HABP4
Negative Regulation Of Cell Motility (GO:2000146),0.127283122,0.354155217,6.839205906,MCTP1;LDLRAD4
Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),0.13057799,0.354155217,15.16766359,LDLRAD4
Regulation Of Dendritic Spine Morphogenesis (GO:0061001),0.13057799,0.354155217,15.16766359,CUX2
Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),0.13057799,0.354155217,15.16766359,BBC3
Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090049),0.13057799,0.354155217,15.16766359,GATA2
Regulation Of Dendrite Morphogenesis (GO:0048814),0.134626869,0.354155217,14.44142017,CUX2
Leukocyte Cell-Cell Adhesion (GO:0007159),0.134626869,0.354155217,14.44142017,SELL
Organic Cation Transport (GO:0015695),0.134626869,0.354155217,14.44142017,SLC35F3
Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),0.134626869,0.354155217,14.44142017,FSTL4
Modulation Of Excitatory Postsynaptic Potential (GO:0098815),0.134626869,0.354155217,14.44142017,CUX2
Central Nervous System Neuron Differentiation (GO:0021953),0.134626869,0.354155217,14.44142017,DRAXIN
Regulation Of Cell Morphogenesis (GO:0022604),0.134626869,0.354155217,14.44142017,WTIP
Regulation Of Cholesterol Efflux (GO:0010874),0.138657095,0.354155217,13.76929649,TTC39B
Positive Regulation Of Synapse Assembly (GO:0051965),0.138657095,0.354155217,13.76929649,CUX2
Phosphatidylinositol 3-Kinase Signaling (GO:0014065),0.138657095,0.354155217,13.76929649,HTR2A
Proteoglycan Biosynthetic Process (GO:0030166),0.138657095,0.354155217,13.76929649,B3GAT3
Mitochondrial Membrane Organization (GO:0007006),0.138657095,0.354155217,13.76929649,SPG7
Negative Regulation Of Endocytosis (GO:0045806),0.142668752,0.354155217,13.14578512,MCTP1
Negative Regulation Of Epithelial Cell Migration (GO:0010633),0.142668752,0.354155217,13.14578512,PTPRG
Carboxylic Acid Metabolic Process (GO:0019752),0.142668752,0.354155217,13.14578512,CYP2J2
Positive Regulation Of RNA Metabolic Process (GO:0051254),0.142668752,0.354155217,13.14578512,HABP4
Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),0.142668752,0.354155217,13.14578512,BBC3
Apoptotic Mitochondrial Changes (GO:0008637),0.146661925,0.354155217,12.56608387,BBC3
Regulation Of Neuronal Synaptic Plasticity (GO:0048168),0.146661925,0.354155217,12.56608387,MCTP1
Membrane Protein Proteolysis (GO:0033619),0.146661925,0.354155217,12.56608387,CTSH
Cellular Response To Hydrogen Peroxide (GO:0070301),0.146661925,0.354155217,12.56608387,ANKZF1
Regulation Of Blood Circulation (GO:1903522),0.146661925,0.354155217,12.56608387,CYP2J2
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),0.150636698,0.359027821,12.02598783,SUSD2
Negative Regulation Of Organelle Assembly (GO:1902116),0.154593156,0.359027821,11.5218005,LIMK2
Regulation Of Intracellular Protein Transport (GO:0033157),0.154593156,0.359027821,11.5218005,B3GAT3
Positive Regulation Of Phospholipase C Activity (GO:0010863),0.154593156,0.359027821,11.5218005,HTR2A
Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),0.154593156,0.359027821,11.5218005,HTR2A
Protein Destabilization (GO:0031648),0.154593156,0.359027821,11.5218005,CTSH
Positive Regulation Of RNA Splicing (GO:0033120),0.154593156,0.359027821,11.5218005,HABP4
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),0.158531381,0.366173026,11.05026022,ATOH8
Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),0.162451456,0.366322397,10.6084789,GATA2
Regulation Of Neurotransmitter Secretion (GO:0046928),0.162451456,0.366322397,10.6084789,MCTP1
Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),0.162451456,0.366322397,10.6084789,SELL
Positive Regulation Of Bone Mineralization (GO:0030501),0.162451456,0.366322397,10.6084789,SLC20A2
Positive Regulation Of Intracellular Transport (GO:0032388),0.166353465,0.366322397,10.19389075,B3GAT3
Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),0.166353465,0.366322397,10.19389075,BBC3
Vitamin Transport (GO:0051180),0.166353465,0.366322397,10.19389075,SLC35F3
Negative Regulation Of Transport (GO:0051051),0.166353465,0.366322397,10.19389075,MCTP1
Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),0.166353465,0.366322397,10.19389075,HTR2A
Regulation Of Small Molecule Metabolic Process (GO:0062012),0.17023749,0.371030426,9.804209131,TTC39B
Positive Regulation Of Catalytic Activity (GO:0043085),0.17023749,0.371030426,9.804209131,B3GAT3
Positive Regulation Of Ossification (GO:0045778),0.174103612,0.373707248,9.437390164,SLC20A2
Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),0.174103612,0.373707248,9.437390164,BBC3
Positive Regulation Of Actin Filament Polymerization (GO:0030838),0.174103612,0.373707248,9.437390164,CDC42EP2
Translational Elongation (GO:0006414),0.177951914,0.378147816,9.091601765,ANKZF1
Monoatomic Cation Transport (GO:0006812),0.177951914,0.378147816,9.091601765,TRPM3
Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),0.181782476,0.379442975,8.765197304,GATA2
Positive Regulation Of Biomineral Tissue Development (GO:0070169),0.181782476,0.379442975,8.765197304,SLC20A2
Regulation Of Cell-Cell Adhesion (GO:0022407),0.181782476,0.379442975,8.765197304,PTPRG
Supramolecular Fiber Organization (GO:0097435),0.182132628,0.379442975,3.553671616,CDC42EP2;NCKAP5;CGNL1
Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),0.18559538,0.382903089,8.456693055,TNS2
Cellular Response To Ketone (GO:1901655),0.18559538,0.382903089,8.456693055,SCNN1G
Zymogen Activation (GO:0031638),0.189390705,0.386976201,8.164748829,CTSH
Regulation Of Apoptotic Signaling Pathway (GO:2001233),0.189390705,0.386976201,8.164748829,CTSH
Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),0.193168533,0.390776383,7.888151282,GATA2
Response To Hydrogen Peroxide (GO:0042542),0.193168533,0.390776383,7.888151282,ANKZF1
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),0.194008981,0.390776383,4.135248672,HTR2A;EIF4G3
Cognition (GO:0050890),0.196928943,0.391218377,7.625799479,CUX2
Proteolysis (GO:0006508),0.198579563,0.391218377,3.226539376,ERMP1;CTSH;SPG7
Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),0.200672014,0.391218377,7.376692362,BBC3
Cellular Response To Mechanical Stimulus (GO:0071260),0.200672014,0.391218377,7.376692362,HABP4
Regulation Of DNA Binding (GO:0051101),0.200672014,0.391218377,7.376692362,HABP4
Myelination (GO:0042552),0.200672014,0.391218377,7.376692362,MAL
Cytoplasmic Microtubule Organization (GO:0031122),0.200672014,0.391218377,7.376692362,LIMK2
Positive Regulation Of Nervous System Development (GO:0051962),0.204397826,0.393072743,7.139917855,CUX2
Unsaturated Fatty Acid Metabolic Process (GO:0033559),0.204397826,0.393072743,7.139917855,CYP2J2
Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.204397826,0.393072743,7.139917855,SELL
"G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187)",0.208106457,0.394619788,6.914643338,HTR2A
Blood Circulation (GO:0008015),0.208106457,0.394619788,6.914643338,F5
Positive Regulation Of Fat Cell Differentiation (GO:0045600),0.208106457,0.394619788,6.914643338,METRNL
SMAD Protein Signal Transduction (GO:0060395),0.211797986,0.394619788,6.700107314,ATOH8
Microtubule Bundle Formation (GO:0001578),0.211797986,0.394619788,6.700107314,NCKAP5
Regulation Of Synapse Assembly (GO:0051963),0.211797986,0.394619788,6.700107314,CUX2
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),0.214344419,0.394619788,3.628379721,ATOH8;GATA2
Negative Regulation Of Response To Stimulus (GO:0048585),0.21547249,0.394619788,6.495612095,MCTP1
Icosanoid Metabolic Process (GO:0006690),0.21547249,0.394619788,6.495612095,CYP2J2
Arachidonic Acid Metabolic Process (GO:0019369),0.21547249,0.394619788,6.495612095,CYP2J2
Regulation Of Protein Localization To Nucleus (GO:1900180),0.21547249,0.394619788,6.495612095,LIMK2
Spermatid Development (GO:0007286),0.219130047,0.394619788,6.300517359,EIF4G3
Actin Cytoskeleton Reorganization (GO:0031532),0.219130047,0.394619788,6.300517359,INSRR
Cellular Response To Alcohol (GO:0097306),0.219130047,0.394619788,6.300517359,SCNN1G
Mitochondrial Transport (GO:0006839),0.219130047,0.394619788,6.300517359,SPG7
Intracellular Monoatomic Cation Homeostasis (GO:0030003),0.221170134,0.39661311,3.478195165,SCNN1G;HTR2A
Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),0.222770735,0.397804883,6.114234467,GATA2
Anterograde Trans-Synaptic Signaling (GO:0098916),0.236590769,0.414200894,3.169571498,HTR2A;CACNA1E
Glycosaminoglycan Biosynthetic Process (GO:0006024),0.237166326,0.414200894,5.446991365,B3GAT3
Regulation Of Phagocytosis (GO:0050764),0.237166326,0.414200894,5.446991365,GATA2
Memory (GO:0007613),0.237166326,0.414200894,5.446991365,CUX2
Regulation Of Bone Mineralization (GO:0030500),0.237166326,0.414200894,5.446991365,SLC20A2
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),0.239865226,0.414200894,2.576675494,CUX2;CTSH;GATA2
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),0.240723814,0.414200894,5.297425077,LDLRAD4
Positive Regulation Of Proteolysis (GO:0045862),0.240723814,0.414200894,5.297425077,CTSH
Cilium Movement (GO:0003341),0.240723814,0.414200894,5.297425077,CABYR
Positive Regulation Of Phagocytosis (GO:0050766),0.244264889,0.416247396,5.153978689,GATA2
Response To Retinoic Acid (GO:0032526),0.244264889,0.416247396,5.153978689,CTSH
Regulation Of Angiogenesis (GO:0045765),0.246906591,0.416247396,2.98390897,CTSH;GATA2
Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),0.247789626,0.416247396,5.016311897,LDLRAD4
Positive Regulation Of Cell Junction Assembly (GO:1901890),0.247789626,0.416247396,5.016311897,CUX2
Negative Regulation Of Autophagy (GO:0010507),0.247789626,0.416247396,5.016311897,EIF4G3
Phosphatidylinositol-Mediated Signaling (GO:0048015),0.2512981,0.420479105,4.884108359,HTR2A
Inorganic Anion Transmembrane Transport (GO:0098661),0.254790385,0.424650642,4.757073657,SLC20A2
Regulation Of Secretion By Cell (GO:1903530),0.258266555,0.428762835,4.634933466,MCTP1
Regulation Of Endocytosis (GO:0030100),0.265170842,0.438512092,4.404329985,MCTP1
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),0.268599105,0.440751428,4.29540438,BBC3
Negative Regulation Of Cellular Catabolic Process (GO:0031330),0.268599105,0.440751428,4.29540438,EIF4G3
Telomere Maintenance (GO:0000723),0.272011546,0.443454,4.190446069,ZBTB48
Regulation Of Heart Contraction (GO:0008016),0.275408236,0.443454,4.08925929,CYP2J2
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.278789247,0.443454,3.99166051,ATOH8
Sulfur Compound Biosynthetic Process (GO:0044272),0.278789247,0.443454,3.99166051,B3GAT3
Positive Regulation Of Protein Polymerization (GO:0032273),0.278789247,0.443454,3.99166051,CDC42EP2
Positive Regulation Of Protein Transport (GO:0051222),0.278789247,0.443454,3.99166051,B3GAT3
Regulation Of Notch Signaling Pathway (GO:0008593),0.278789247,0.443454,3.99166051,GATA2
Regulation Of Actin Filament Polymerization (GO:0030833),0.278789247,0.443454,3.99166051,CDC42EP2
Regulation Of Cilium Assembly (GO:1902017),0.282154651,0.443454,3.897477504,LIMK2
Kidney Development (GO:0001822),0.282154651,0.443454,3.897477504,CTSH
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),0.285504519,0.443454,3.806548511,LIMK2
Cholesterol Homeostasis (GO:0042632),0.285504519,0.443454,3.806548511,TTC39B
Second-Messenger-Mediated Signaling (GO:0019932),0.285504519,0.443454,3.806548511,MCTP1
Apoptotic Process (GO:0006915),0.286538534,0.443454,2.392194168,MAL;BBC3
Sterol Homeostasis (GO:0055092),0.288838921,0.443454,3.718721471,TTC39B
Ubiquitin-Dependent ERAD Pathway (GO:0030433),0.288838921,0.443454,3.718721471,ANKZF1
Cellular Response To Reactive Oxygen Species (GO:0034614),0.288838921,0.443454,3.718721471,ANKZF1
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),0.29170254,0.443454,2.32676263,WTIP;CGNL1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.29170254,0.443454,2.32676263,LDLRAD4;PTPRG
Positive Regulation Of Phosphorylation (GO:0042327),0.29170254,0.443454,2.32676263,LIMK2;INSRR
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),0.29215793,0.443454,3.633853315,SUSD2
Positive Regulation Of Neurogenesis (GO:0050769),0.295461614,0.443714438,3.551809331,CUX2
Regulation Of Stress Fiber Assembly (GO:0051492),0.295461614,0.443714438,3.551809331,CGNL1
Regulation Of BMP Signaling Pathway (GO:0030510),0.295461614,0.443714438,3.551809331,FSTL4
Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),0.302023289,0.448810832,3.395693293,LDLRAD4
Monoatomic Cation Homeostasis (GO:0055080),0.302023289,0.448810832,3.395693293,SCNN1G
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),0.302023289,0.448810832,3.395693293,GATA2
Long-Chain Fatty Acid Metabolic Process (GO:0001676),0.30528142,0.450594207,3.321388507,CYP2J2
Positive Regulation Of Protein Localization To Membrane (GO:1905477),0.308524504,0.450594207,3.249441477,BBC3
Positive Regulation Of Cytoskeleton Organization (GO:0051495),0.308524504,0.450594207,3.249441477,CDC42EP2
Positive Regulation Of Endocytosis (GO:0045807),0.308524504,0.450594207,3.249441477,GATA2
Negative Regulation Of Cellular Component Organization (GO:0051129),0.308524504,0.450594207,3.249441477,MCTP1
Calcium Ion Transmembrane Transport (GO:0070588),0.311752611,0.45374952,3.179751318,TRPM3
Cytoskeleton-Dependent Cytokinesis (GO:0061640),0.314965809,0.456861669,3.112222607,SPIRE1
Sodium Ion Transmembrane Transport (GO:0035725),0.318164166,0.459841057,3.046765027,SCNN1G
Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.321347751,0.459841057,2.983293033,LDLRAD4
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),0.321347751,0.459841057,2.983293033,HTR2A
Regulation Of Cell Division (GO:0051302),0.321347751,0.459841057,2.983293033,SUSD2
Positive Regulation Of Double-Strand Break Repair (GO:2000781),0.324516629,0.460433802,2.921725551,SPIRE1
Regulation Of Kinase Activity (GO:0043549),0.32767087,0.460433802,2.861985692,INSRR
Positive Regulation Of Protein Localization (GO:1903829),0.32767087,0.460433802,2.861985692,LIMK2
Calcium-Mediated Signaling (GO:0019722),0.32767087,0.460433802,2.861985692,MCTP1
Positive Regulation Of Amide Metabolic Process (GO:0034250),0.32767087,0.460433802,2.861985692,EIF4G3
Regulation Of Cell Migration (GO:0030334),0.328262217,0.460433802,1.677892118,MCTP1;CTSH;LDLRAD4
Negative Regulation Of Binding (GO:0051100),0.330810539,0.462481839,2.804000496,HABP4
Regulation Of Double-Strand Break Repair (GO:2000779),0.337046428,0.463335519,2.693020433,SPIRE1
Regulation Of Endothelial Cell Migration (GO:0010594),0.337046428,0.463335519,2.693020433,ATOH8
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),0.337046428,0.463335519,2.693020433,CDC42EP2
ERAD Pathway (GO:0036503),0.340142781,0.463335519,2.639897176,ANKZF1
Cellular Response To Chemical Stress (GO:0062197),0.340142781,0.463335519,2.639897176,ERMP1
Cellular Response To Peptide Hormone Stimulus (GO:0071375),0.340142781,0.463335519,2.639897176,SCNN1G
Positive Regulation Of DNA Repair (GO:0045739),0.340142781,0.463335519,2.639897176,SPIRE1
Sodium Ion Transport (GO:0006814),0.340142781,0.463335519,2.639897176,SCNN1G
Positive Regulation Of Neuron Projection Development (GO:0010976),0.34934626,0.471918811,2.489288428,CUX2
Positive Regulation Of Signal Transduction (GO:0009967),0.351420876,0.471918811,1.710129354,CUX2;CTSH
Regulation Of Endothelial Cell Proliferation (GO:0001936),0.352385777,0.471918811,2.441825925,ATOH8
Cytoplasmic Translation (GO:0002181),0.352385777,0.471918811,2.441825925,RPS29
Positive Regulation Of Cellular Component Biogenesis (GO:0044089),0.352385777,0.471918811,2.441825925,CDC42EP2
Negative Regulation Of Signal Transduction (GO:0009968),0.35310631,0.471918811,1.695795071,GATA2;TNS2
Cellular Response To Hormone Stimulus (GO:0032870),0.355411246,0.473510281,2.395649975,CTSH
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),0.3614203,0.480011336,2.306973049,CDC42EP2
Chemical Synaptic Transmission (GO:0007268),0.363187356,0.480855534,1.612915652,HTR2A;CACNA1E
Monocarboxylic Acid Metabolic Process (GO:0032787),0.364404012,0.480968029,2.264384969,CYP2J2
MAPK Cascade (GO:0000165),0.367373933,0.481894819,2.222909001,CTSH
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),0.367373933,0.481894819,2.222909001,CDC42EP2
Monoatomic Cation Transmembrane Transport (GO:0098655),0.376538501,0.491233855,1.510209472,SCNN1G;TRPM3
Calcium Ion Homeostasis (GO:0055074),0.379116951,0.491233855,2.067374969,HTR2A
Protein Catabolic Process (GO:0030163),0.379116951,0.491233855,2.067374969,CTSH
Regulation Of RNA Splicing (GO:0043484),0.379116951,0.491233855,2.067374969,HABP4
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),0.381516653,0.491347204,1.473826302,INSRR;PTPRG
Inorganic Cation Transmembrane Transport (GO:0098662),0.381516653,0.491347204,1.473826302,SCNN1G;TRPM3
Positive Regulation Of Kinase Activity (GO:0033674),0.384907335,0.494216366,1.99534843,INSRR
Intrinsic Apoptotic Signaling Pathway (GO:0097193),0.387782461,0.496408271,1.960660018,BBC3
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),0.39915062,0.508938928,1.830085256,BBC3
Response To Lipid (GO:0033993),0.401959874,0.508938928,1.799357479,CTSH
Negative Regulation Of Inflammatory Response (GO:0050728),0.404756135,0.508938928,1.769348127,METRNL
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),0.404756135,0.508938928,1.769348127,LDLRAD4
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.404756135,0.508938928,1.769348127,LDLRAD4
Cytoskeleton Organization (GO:0007010),0.404756135,0.508938928,1.769348127,WTIP
Calcium Ion Transport (GO:0006816),0.407539461,0.509424327,1.740034889,TRPM3
Negative Regulation Of Defense Response (GO:0031348),0.407539461,0.509424327,1.740034889,METRNL
Positive Regulation Of Cellular Component Organization (GO:0051130),0.410309912,0.511383322,1.711396322,CDC42EP2
Response To Endoplasmic Reticulum Stress (GO:0034976),0.413067547,0.511818389,1.683411819,BBC3
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),0.413067547,0.511818389,1.683411819,DRAXIN
Cellular Response To Oxidative Stress (GO:0034599),0.421264136,0.520457145,1.603188279,ERMP1
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),0.423971088,0.520773735,1.577629264,CGNL1
Positive Regulation Of Cell Projection Organization (GO:0031346),0.423971088,0.520773735,1.577629264,CUX2
Regulation Of Protein-Containing Complex Assembly (GO:0043254),0.426665514,0.522573036,1.552632456,CDC42EP2
Fatty Acid Metabolic Process (GO:0006631),0.43467421,0.529331058,1.48085461,CYP2J2
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),0.43467421,0.529331058,1.48085461,EIF4G3
Modulation Of Chemical Synaptic Transmission (GO:0050804),0.437319103,0.53103034,1.457948853,MCTP1
Neuron Projection Guidance (GO:0097485),0.439951755,0.532705116,1.435529218,DRAXIN
Response To Cytokine (GO:0034097),0.442572221,0.534355665,1.413582085,SELL
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),0.447776819,0.539108068,1.371053231,WTIP
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),0.455493708,0.546849791,1.310489772,ATOH8
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),0.460578936,0.551397318,1.272134066,TTC17
Negative Regulation Of Gene Expression (GO:0010629),0.464817597,0.554908648,0.986712854,ATOH8;GATA2
Protein Localization To Plasma Membrane (GO:0072659),0.473087381,0.563199264,1.182712801,RAB40B
Intracellular Calcium Ion Homeostasis (GO:0006874),0.478010029,0.567470007,1.149335599,HTR2A
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.480454265,0.568782904,1.133125068,DRAXIN
Protein Localization To Cell Periphery (GO:1990778),0.485308819,0.572934022,1.101620572,RAB40B
Positive Regulation Of Transferase Activity (GO:0051347),0.487719242,0.574184703,1.086311517,INSRR
Negative Regulation Of Response To External Stimulus (GO:0032102),0.494883707,0.581009877,1.042071414,METRNL
Dephosphorylation (GO:0016311),0.497249764,0.582179476,1.027864524,PTPRG
Negative Regulation Of Protein Phosphorylation (GO:0001933),0.501949036,0.584461207,1.000222007,LDLRAD4
Axon Guidance (GO:0007411),0.501949036,0.584461207,1.000222007,DRAXIN
Peptide Biosynthetic Process (GO:0043043),0.522563688,0.606802097,0.887421499,RPS29
Negative Regulation Of Cell Population Proliferation (GO:0008285),0.528602299,0.612141627,0.72584281,GATA2;TNS2
Protein Autophosphorylation (GO:0046777),0.531452627,0.613770018,0.842712695,INSRR
Nitrogen Compound Transport (GO:0071705),0.533649159,0.614636565,0.832004092,SLC35F3
Metal Ion Transport (GO:0030001),0.550858576,0.631747749,0.752475865,SCNN1G
Generation Of Neurons (GO:0048699),0.552965088,0.631747749,0.743249343,LMX1A
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),0.552965088,0.631747749,0.743249343,SELL
Neuron Differentiation (GO:0030182),0.555061827,0.632443101,0.734170649,LMX1A
Positive Regulation Of Hydrolase Activity (GO:0051345),0.561293846,0.637833916,0.7077914,CTSH
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),0.567439502,0.643098102,0.682637302,HTR2A
Macromolecule Biosynthetic Process (GO:0009059),0.575501411,0.650500265,0.650879763,RPS29
Phosphate-Containing Compound Metabolic Process (GO:0006796),0.577493552,0.651020582,0.643241865,LIMK2
Organelle Organization (GO:0006996),0.58191859,0.654273547,0.557529017,WTIP;TTC17
Axonogenesis (GO:0007409),0.585370049,0.656417601,0.613826918,DRAXIN
Protein Localization To Membrane (GO:0072657),0.593101259,0.663336935,0.586128155,RAB40B
Positive Regulation Of Protein Metabolic Process (GO:0051247),0.600689834,0.668642621,0.560019196,EIF4G3
Nervous System Development (GO:0007399),0.60123128,0.668642621,0.50528612,MAL;SPG7
Golgi Vesicle Transport (GO:0048193),0.602564997,0.668642621,0.553726655,SPIRE1
Regulation Of Gene Expression (GO:0010468),0.607133823,0.671958008,0.474691529,CUX2;ATOH8;CTSH;GATA2;WTIP
Regulation Of Translation (GO:0006417),0.611810936,0.675375709,0.523587921,EIF4G3
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.620844036,0.681805466,0.495514015,DRAXIN
Negative Regulation Of Cell Differentiation (GO:0045596),0.620844036,0.681805466,0.495514015,LDLRAD4
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),0.640165632,0.701212355,0.407212935,LMX1A;ATOH8;OTX1;GATA2
Positive Regulation Of Cell Motility (GO:2000147),0.645045257,0.704740962,0.426455825,CTSH
Positive Regulation Of Protein Modification Process (GO:0031401),0.651674721,0.71015835,0.408989336,LIMK2
Cilium Organization (GO:0044782),0.656566298,0.713659019,0.396475674,TTC17
Positive Regulation Of Developmental Process (GO:0051094),0.664568354,0.720387425,0.376665579,SPIRE1
Translation (GO:0006412),0.66614649,0.720387425,0.372853026,RPS29
Regulation Of Inflammatory Response (GO:0050727),0.675462232,0.728406592,0.350959515,METRNL
Regulation Of Autophagy (GO:0010506),0.676989656,0.728406592,0.347467512,EIF4G3
Protein Phosphorylation (GO:0006468),0.67937391,0.729126039,0.331135602,LIMK2;INSRR
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),0.681529386,0.729596949,0.337246844,HTR2A
Positive Regulation Of DNA-templated Transcription (GO:0045893),0.693211941,0.740238882,0.313954213,LMX1A;ZBTB48;ATOH8;OTX1;GATA2
Regulation Of Protein Phosphorylation (GO:0001932),0.711587745,0.757956871,0.275183602,LIMK2
Negative Regulation Of Cellular Process (GO:0048523),0.716986304,0.761312004,0.264764758,SUSD2;TNS2
Positive Regulation Of Apoptotic Process (GO:0043065),0.718320268,0.761312004,0.262527521,CTSH
Positive Regulation Of Cell Migration (GO:0030335),0.720969533,0.762219034,0.257664139,CTSH
Central Nervous System Development (GO:0007417),0.73510588,0.77399676,0.232786461,MAL
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.735752214,0.77399676,0.235160525,ZBTB48;ATOH8
Gene Expression (GO:0010467),0.75090133,0.787982877,0.207017899,RPS29
Positive Regulation Of MAPK Cascade (GO:0043410),0.766870708,0.802758747,0.182989851,HTR2A
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),0.77659747,0.810943305,0.169289991,ANKZF1
Protein Localization (GO:0008104),0.808040128,0.841708467,0.129454925,MAL
Positive Regulation Of Protein Phosphorylation (GO:0001934),0.830329743,0.86281208,0.104979338,LIMK2
Negative Regulation Of Programmed Cell Death (GO:0043069),0.833523658,0.864018426,0.101708633,CTSH
Regulation Of Transcription By RNA Polymerase II (GO:0006357),0.844432088,0.873196199,0.1218055,MGAM;CUX2;LMX1A;ZBTB48;ATOH8;OTX1;GATA2
Protein Modification Process (GO:0036211),0.847804836,0.874555959,0.098255778,LIMK2;PTPRG
Vesicle-Mediated Transport (GO:0016192),0.855655637,0.880517302,0.080576199,SPIRE1
Negative Regulation Of DNA-templated Transcription (GO:0045892),0.861789187,0.884686968,0.091619106,CUX2;ATOH8;GATA2
Phosphorylation (GO:0016310),0.867510151,0.88841401,0.070309645,LIMK2
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),0.874691088,0.89290978,0.074030774,CUX2;GATA2
Regulation Of Cell Population Proliferation (GO:0042127),0.876102067,0.89290978,0.072840916,CTSH;TNS2
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.881265376,0.896023409,0.05926853,WTIP
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),0.883508969,0.896160649,0.057553866,ATOH8
Regulation Of DNA-templated Transcription (GO:0006355),0.893099558,0.903731695,0.073213318,MGAM;LMX1A;ZBTB48;ATOH8;OTX1;WTIP
Negative Regulation Of Apoptotic Process (GO:0043066),0.897103806,0.90397508,0.047666703,CTSH
Positive Regulation Of Cell Population Proliferation (GO:0008284),0.89759408,0.90397508,0.047326027,CTSH
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),0.916225758,0.920557795,0.03517812,BBC3
Positive Regulation Of Cellular Process (GO:0048522),0.939824397,0.942040964,0.021971368,CTSH
Regulation Of Apoptotic Process (GO:0042981),0.964747231,0.964747231,0.010640738,CTSH
Peptidase Activator Activity Involved In Apoptotic Process (GO:0016505),0.004650876,0.33068305,117.370444,CTSH;MAL
Calcium Channel Activity (GO:0005262),0.008803639,0.33068305,35.52848638,NALF1;CACNA1E;TRPM3
Monoatomic Ion Channel Activity (GO:0005216),0.012817171,0.33068305,54.36841348,SCNN1G;TRPM3
Monoatomic Cation Channel Activity (GO:0005261),0.012967963,0.33068305,28.12357485,SCNN1G;CACNA1E;TRPM3
Alpha-Glucosidase Activity (GO:0090599),0.027580896,0.385917069,155.3494713,MGAM
Inorganic Phosphate Transmembrane Transporter Activity (GO:0005315),0.032103986,0.385917069,123.9765628,SLC20A2
Double-Stranded Telomeric DNA Binding (GO:0003691),0.036606265,0.385917069,102.204913,ZBTB48
Protein Tyrosine Phosphatase Activity (GO:0004725),0.048829384,0.385917069,17.78563011,TNS2;PTPRG
C2H2 Zinc Finger Domain Binding (GO:0070742),0.04998917,0.385917069,64.79390764,GATA2
Ligand-Gated Sodium Channel Activity (GO:0015280),0.04998917,0.385917069,64.79390764,SCNN1G
Sodium:Phosphate Symporter Activity (GO:0005436),0.04998917,0.385917069,64.79390764,SLC20A2
"3',5'-cyclic-AMP Phosphodiesterase Activity (GO:0004115)",0.058808769,0.385917069,51.06138806,PDE8B
SUMO Binding (GO:0032183),0.063188145,0.385917069,45.93648646,HABP4
Arachidonic Acid Epoxygenase Activity (GO:0008392),0.067547363,0.385917069,41.62280132,CYP2J2
"3',5'-Cyclic-Nucleotide Phosphodiesterase Activity (GO:0004114)",0.071886513,0.385917069,37.94855382,PDE8B
Transmembrane Receptor Protein Phosphatase Activity (GO:0019198),0.071886513,0.385917069,37.94855382,PTPRG
Arachidonic Acid Monooxygenase Activity (GO:0008391),0.071886513,0.385917069,37.94855382,CYP2J2
Transmembrane Receptor Protein Tyrosine Phosphatase Activity (GO:0005001),0.071886513,0.385917069,37.94855382,PTPRG
Calcium-Dependent Phospholipase A2 Activity (GO:0047498),0.071886513,0.385917069,37.94855382,PLA2G12A
R-SMAD Binding (GO:0070412),0.084784473,0.394891955,29.63704635,LDLRAD4
RNA Cap Binding (GO:0000339),0.084784473,0.394891955,29.63704635,EIF4G3
Cysteine-Type Endopeptidase Activator Activity Involved In Apoptotic Process (GO:0008656),0.089044264,0.394891955,27.51804806,CTSH
WW Domain Binding (GO:0050699),0.089044264,0.394891955,27.51804806,SCNN1G
G Protein-Coupled Serotonin Receptor Activity (GO:0004993),0.093284441,0.396458875,25.63803881,HTR2A
High Voltage-Gated Calcium Channel Activity (GO:0008331),0.101706309,0.402283149,22.45576451,CACNA1E
Peptidase Activator Activity (GO:0016504),0.105888176,0.402283149,21.09970251,MAL
"Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, Reduced Flavin Or Flavoprotein As One Donor, And Incorporation Of One Atom Of Oxygen (GO:0016712)",0.110050785,0.402283149,19.87231415,CYP2J2
Serotonin Receptor Activity (GO:0099589),0.114194221,0.402283149,18.75697777,HTR2A
Voltage-Gated Monoatomic Ion Channel Activity (GO:0005244),0.118318573,0.402283149,17.73975745,CACNA1E
N-methyltransferase Activity (GO:0008170),0.118318573,0.402283149,17.73975745,METTL15
G Protein-Coupled Amine Receptor Activity (GO:0008227),0.122423928,0.402814213,16.80888767,HTR2A
Aminopeptidase Activity (GO:0004177),0.126510371,0.403251807,15.95437137,CTSH
Glucuronosyltransferase Activity (GO:0015020),0.13057799,0.403604695,15.16766359,B3GAT3
Phospholipase A2 Activity (GO:0004623),0.134626869,0.403880607,14.44142017,PLA2G12A
Telomeric DNA Binding (GO:0042162),0.142668752,0.40425502,13.14578512,ZBTB48
Sodium Ion Transmembrane Transporter Activity (GO:0015081),0.146661925,0.40425502,12.56608387,SCNN1G
Solute:Sodium Symporter Activity (GO:0015370),0.146661925,0.40425502,12.56608387,SLC20A2
Transmembrane Receptor Protein Kinase Activity (GO:0019199),0.158531381,0.40425502,11.05026022,INSRR
Monoatomic Cation Transmembrane Transporter Activity (GO:0008324),0.158531381,0.40425502,11.05026022,TRPM3
Sodium Channel Activity (GO:0005272),0.158531381,0.40425502,11.05026022,SCNN1G
"Catalytic Activity, Acting On A tRNA (GO:0140101)",0.166353465,0.412989963,10.19389075,ANKZF1
Translation Initiation Factor Activity (GO:0003743),0.174103612,0.412989963,9.437390164,EIF4G3
RNA Endonuclease Activity (GO:0004521),0.174103612,0.412989963,9.437390164,ANKZF1
Double-Stranded DNA Binding (GO:0003690),0.185357494,0.42722061,2.859892732,CUX2;LMX1A;ZBTB48;OTX1;GATA2
Voltage-Gated Calcium Channel Activity (GO:0005245),0.196928943,0.42722061,7.625799479,CACNA1E
Calcium-Dependent Phospholipid Binding (GO:0005544),0.196928943,0.42722061,7.625799479,MCTP1
Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714),0.208106457,0.42722061,6.914643338,INSRR
tRNA Binding (GO:0000049),0.211797986,0.42722061,6.700107314,C6ORF52
E-box Binding (GO:0070888),0.211797986,0.42722061,6.700107314,ATOH8
Channel Activity (GO:0015267),0.21547249,0.42722061,6.495612095,SCNN1G
Exopeptidase Activity (GO:0008238),0.21547249,0.42722061,6.495612095,CTSH
Calcium Ion Binding (GO:0005509),0.217798742,0.42722061,2.8978749,MCTP1;CABYR;SELL
Endonuclease Activity (GO:0004519),0.237166326,0.435767964,5.446991365,ANKZF1
Sequence-Specific Double-Stranded DNA Binding (GO:1990837),0.239328157,0.435767964,2.196716318,CUX2;LMX1A;ZBTB48;OTX1;GATA2
SH3 Domain Binding (GO:0017124),0.240723814,0.435767964,5.297425077,CABYR
Secondary Active Transmembrane Transporter Activity (GO:0015291),0.244264889,0.435767964,5.153978689,SLC20A2
Protein Phosphatase Regulator Activity (GO:0019888),0.247789626,0.435767964,5.016311897,B3GAT3
UDP-glycosyltransferase Activity (GO:0008194),0.247789626,0.435767964,5.016311897,B3GAT3
Calcium Ion Transmembrane Transporter Activity (GO:0015085),0.272011546,0.470257249,4.190446069,TRPM3
RNA Nuclease Activity (GO:0004540),0.278789247,0.47394172,3.99166051,ANKZF1
ATPase Binding (GO:0051117),0.288838921,0.473944239,3.718721471,BBC3
Hormone Activity (GO:0005179),0.29215793,0.473944239,3.633853315,METRNL
Ligand-Gated Monoatomic Cation Channel Activity (GO:0099094),0.295461614,0.473944239,3.551809331,SCNN1G
Voltage-Gated Monoatomic Cation Channel Activity (GO:0022843),0.298750044,0.473944239,3.472462566,CACNA1E
Phospholipase Activity (GO:0004620),0.302023289,0.473944239,3.395693293,PLA2G12A
Heme Binding (GO:0020037),0.333935703,0.51608245,2.747700683,CYP2J2
RNA Polymerase II Transcription Regulatory Region Sequence-Specific DNA Binding (GO:0000977),0.343284634,0.522612427,1.335350957,MGAM;CUX2;LMX1A;ZBTB48;OTX1;GATA2;ZNF665
Hexosyltransferase Activity (GO:0016758),0.3614203,0.537124242,2.306973049,B3GAT3
Transcription Coregulator Binding (GO:0001221),0.370330124,0.537124242,2.182506325,GATA2
Protein Tyrosine Kinase Activity (GO:0004713),0.370330124,0.537124242,2.182506325,INSRR
Metalloendopeptidase Activity (GO:0004222),0.376201571,0.537124242,2.104774032,SPG7
Transcription Cis-Regulatory Region Binding (GO:0000976),0.379146524,0.537124242,1.334017359,CUX2;LMX1A;ZBTB48
Carboxylic Ester Hydrolase Activity (GO:0052689),0.384907335,0.537815728,1.99534843,PLA2G12A
Cysteine-Type Endopeptidase Activity (GO:0004197),0.390644292,0.538455646,1.926816333,CTSH
RNA Polymerase II Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000978),0.423240647,0.564279582,0.998440958,MGAM;ZBTB48;ATOH8;OTX1;GATA2;ZNF665
Sequence-Specific DNA Binding (GO:0043565),0.428658772,0.564279582,1.024890793,CUX2;LMX1A;OTX1;GATA2
Metal Ion Binding (GO:0046872),0.437888165,0.564279582,1.030326636,MCTP1;CABYR;SELL
Metallopeptidase Activity (GO:0008237),0.439951755,0.564279582,1.435529218,SPG7
Protease Binding (GO:0002020),0.442572221,0.564279582,1.413582085,SELL
Serine-Type Endopeptidase Activity (GO:0004252),0.442572221,0.564279582,1.413582085,CTSH
Endopeptidase Activity (GO:0004175),0.463275456,0.583383907,0.994019776,CTSH;SPG7
Serine-Type Peptidase Activity (GO:0008236),0.485308819,0.602314297,1.101620572,CTSH
Cysteine-Type Peptidase Activity (GO:0008234),0.490118496,0.602314297,1.071288252,CTSH
Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000987),0.583659052,0.708728849,0.526604104,MGAM;ZBTB48;OTX1;GATA2;ZNF665
Small GTPase Binding (GO:0031267),0.606289228,0.727547074,0.541411221,CDC42EP2
GTPase Activator Activity (GO:0005096),0.627920533,0.744742958,0.474422085,CDC42EP2
Transcription Regulatory Region Nucleic Acid Binding (GO:0001067),0.650028929,0.75246924,0.413270369,ZBTB48
GTPase Binding (GO:0051020),0.651674721,0.75246924,0.408989336,CDC42EP2
RNA Polymerase II-specific DNA-binding Transcription Factor Binding (GO:0061629),0.656566298,0.75246924,0.396475674,GATA2
GTPase Activity (GO:0003924),0.711587745,0.804868392,0.275183602,RAB40B
Ribonucleoside Triphosphate Phosphatase Activity (GO:0017111),0.718320268,0.804868392,0.262527521,RAB40B
DNA-binding Transcription Factor Binding (GO:0140297),0.733850592,0.804868392,0.234924271,GATA2
mRNA Binding (GO:0003729),0.733850592,0.804868392,0.234924271,EIF4G3
Receptor Ligand Activity (GO:0048018),0.77659747,0.842690872,0.169289991,METRNL
Zinc Ion Binding (GO:0008270),0.798716235,0.846798481,0.140590613,RPS29
Protein Serine/Threonine Kinase Activity (GO:0004674),0.799668432,0.846798481,0.13942808,LIMK2
"DNA-binding Transcription Activator Activity, RNA Polymerase II-specific (GO:0001228)",0.805288751,0.846798481,0.132683982,OTX1
GTPase Regulator Activity (GO:0030695),0.8643174,0.899595661,0.073005028,CDC42EP2
Transition Metal Ion Binding (GO:0046914),0.883508969,0.903424826,0.057553866,RPS29
Kinase Binding (GO:0019900),0.885710613,0.903424826,0.055894349,TNS2
RNA Binding (GO:0003723),0.964018027,0.97356276,0.016048795,HABP4;C6ORF52;EIF4G3
DNA Binding (GO:0003677),0.982205839,0.982205839,0.004402449,CUX2
Linoleic acid metabolism,0.008003632,0.448203393,78.12605095,CYP2J2;PLA2G12A
Arachidonic acid metabolism,0.032780709,0.605086477,25.27054507,CYP2J2;PLA2G12A
Inflammatory mediator regulation of TRP channels,0.076321707,0.605086477,11.66888711,CYP2J2;HTR2A
One carbon pool by folate,0.089044264,0.605086477,27.51804806,AMT
Serotonergic synapse,0.097248899,0.605086477,9.134583545,CYP2J2;HTR2A
alpha-Linolenic acid metabolism,0.110050785,0.605086477,19.87231415,PLA2G12A
Glyoxylate and dicarboxylate metabolism,0.13057799,0.605086477,15.16766359,AMT
Galactose metabolism,0.134626869,0.605086477,14.44142017,MGAM
Apoptosis,0.141435546,0.605086477,6.069465649,CTSH;BBC3
Starch and sucrose metabolism,0.154593156,0.605086477,11.5218005,MGAM
Aldosterone-regulated sodium reabsorption,0.158531381,0.605086477,11.05026022,SCNN1G
"Glycine, serine and threonine metabolism",0.17023749,0.605086477,9.804209131,AMT
Hippo signaling pathway,0.175614321,0.605086477,4.688755285,WTIP;BBC3
Fat digestion and absorption,0.181782476,0.605086477,8.765197304,PLA2G12A
Type II diabetes mellitus,0.193168533,0.605086477,7.888151282,CACNA1E
Carbohydrate digestion and absorption,0.196928943,0.605086477,7.625799479,MGAM
Ether lipid metabolism,0.204397826,0.605086477,7.139917855,PLA2G12A
Cysteine and methionine metabolism,0.208106457,0.605086477,6.914643338,ADI1
Ovarian steroidogenesis,0.211797986,0.605086477,6.700107314,CYP2J2
Glycosaminoglycan biosynthesis,0.219130047,0.605086477,6.300517359,B3GAT3
Viral myocarditis,0.244264889,0.605086477,5.153978689,EIF4G3
Cortisol synthesis and secretion,0.261726682,0.605086477,4.517431892,PDE8B
Regulation of actin cytoskeleton,0.269306067,0.605086477,2.628485532,LIMK2;INSRR
p53 signaling pathway,0.288838921,0.605086477,3.718721471,BBC3
Calcium signaling pathway,0.307165529,0.605086477,2.143934615,HTR2A;CACNA1E
Complement and coagulation cascades,0.32767087,0.605086477,2.861985692,F5
Taste transduction,0.330810539,0.605086477,2.804000496,SCNN1G
Colorectal cancer,0.330810539,0.605086477,2.804000496,BBC3
ECM-receptor interaction,0.337046428,0.605086477,2.693020433,SV2C
Gap junction,0.337046428,0.605086477,2.693020433,HTR2A
Morphine addiction,0.346292632,0.605086477,2.538086459,PDE8B
Fc gamma R-mediated phagocytosis,0.364404012,0.605086477,2.264384969,LIMK2
Prostate cancer,0.364404012,0.605086477,2.264384969,INSRR
Glycerophospholipid metabolism,0.367373933,0.605086477,2.222909001,PLA2G12A
Pancreatic secretion,0.379116951,0.606587122,2.067374969,PLA2G12A
Lysosome,0.450361061,0.667929105,1.35044659,CTSH
Purine metabolism,0.452933339,0.667929105,1.330262575,PDE8B
Vascular smooth muscle contraction,0.463103904,0.667929105,1.253530209,PLA2G12A
Measles,0.478010029,0.667929105,1.149335599,BBC3
Signaling pathways regulating pluripotency of stem cells,0.487719242,0.667929105,1.086311517,OTX1
Cell adhesion molecules,0.499604858,0.667929105,1.013916777,SELL
Cushing syndrome,0.515787697,0.667929105,0.923042908,PDE8B
Ribosome,0.522563688,0.667929105,0.887421499,RPS29
Necroptosis,0.52480144,0.667929105,0.875954692,SPATA2L
Tight junction,0.546616048,0.680233304,0.771385007,CGNL1
Axon guidance,0.573499979,0.692791643,0.658635858,LIMK2
RNA transport,0.581450129,0.692791643,0.628311487,EIF4G3
Human immunodeficiency virus 1 infection,0.629669145,0.725561542,0.469328087,LIMK2
Lipid and atherosclerosis,0.634866349,0.725561542,0.454456161,CYP2J2
Coronavirus disease,0.662982838,0.727981156,0.380526891,RPS29
Ras signaling pathway,0.662982838,0.727981156,0.380526891,PLA2G12A
MAPK signaling pathway,0.748533354,0.80556986,0.210750462,CACNA1E
Huntington disease,0.762414332,0.80556986,0.189498897,BBC3
Neuroactive ligand-receptor interaction,0.798716235,0.828298318,0.140590613,HTR2A
Herpes simplex virus 1 infection,0.904676809,0.918597839,0.042525711,ZNF665
Pathways in cancer,0.918597839,0.918597839,0.033741596,BBC3